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DAI ABSTRACT 
The synthesis of a tryptophan specific reagent, 
dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl} sulfoniurn 
bromide, is described. The synthetic route incorporated 
3H and 14c. The reagent was shown to specifically benzylate 
tryptophan which was either in solution as a free amino 
acid or in a protein. Physicochemical properties of the 
reagent which may be related to its specificity were examined. 
Evidence is presented that a conformational change 
occurs in mouse IgG2a when antigen binds and that this 
change is a necessary condition for the activation of the 
complement cascade. A 3H;14c-labeled, tryptophan-specific 
reagent was used to monitor the reactivity of tryptophans 
in the Fe region of the immunoglobulin. This reactivity 
correlated with the ability of the antibody to fix complement. 
Thus binding monovalent and multivalent antigens caused 
decreases in the reactivity of Fe tryptophan residues by 
15% and 22%, respectively. Hapten had no effect on the 
reactivity of these residues. After reduction and alkylation 
of disulfide bonds in the IgG to an extent which abolished 
the antibody's ability to fix complement, the reactivity of 
Fe tryptophan did not change when monovalent antigen was 
bound. The Fe tryptophan reactivity of similarly reduced 
and alkylated IgG increased by 25% when multivalent antigen 
was bound. 
v 
A combined classical-alternate pathway assay was 
developed which distinguishes effects on those components 
preceeding C3 in the complement cascade from effects on C3 
and later components. When antigen-antibody aggregates were 
assayed by this method, fixation was observed in both 
the classical and alternate pathways. However, when 
oligomers of mouse IgG2a produced by chemical crosslinking 
were assayed, no fixation of the components of the alternate 
pathway was observed. The time course of classical pathway 
fixation by these synthetic oligomers indicates that some 
of the components preceding C3 in the cascade were being 
enzymatically degraded. 
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Two mechanisms for the activation of complement by IgG 
are presented in this chapter. Previously reported evidence 
in support of each mechanism is reviewed and areas that are 
mechanistically uncertain are discussed. 
Chapter 2 
The synthesis of a tryptophan specific reagent, dimethyl 
(2-hydroxy-3-methyl-5-nitrobenzyl) sulfoniurn bromide, is 
described. The synthetic route incorporated tritium and 
14c thereby allowing the reagent to be used in a double 
radiolabeling paradigm. The reagent was shown to specifi-
cally benzylate tryptophan which was either in solution or 
in a protein. Physicochemical properties of the reagent 
which may give rise to this specificity were examined. 
Chapter 3 
This chapter presents evidence that a conformational 
change occurs in mouse IgG2a when antigen binds and that 
this change is a necessary condition for the activation of 
the complement cascade. A 3H;14c-labeled reagent, which 
reacts specifically with tryptophan residues, was used to 
monitor the reactivity of tryptophans in the Fe region of 
the immunoglobulin. This reactivity correlated with the 
ability of the antibody to fix complement. Thus binding 
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monovalent and multivalent antigens caused decreases in 
the reactivity of Fe tryptophan residues by 15% and 22% 
respectively. Hapten had no effect on the reactivity of 
these residues. After reduction and alkylation of 
disulfide bonds in the IgG to an extent which abolished 
the antibody's ability to fix complement, the reactivity of 
Fe tryptophan residues did not change when monovalent antigen 
was bound. The Fe tryptophan reactivity of similarly 
reduced and alkylated IgG increased by 25% when multivalent 
antigen was bound. 
Chapter 4 
A combined classical pathway - alternate pathway complement 
fixation assay has been developed which distinguishes effects 
on those components preceding C3 in the cascade from 
effects on C3 and later components. When antigen-antibody 
aggregates are assayed by this method, fixation is observed 
in both the classical pathway and alternate pathway. 
However, when oligomers of mouse IgG2a, produced by chemical 
crosslinking, are assayed, no fixation of the components of 
the alternate pathway is observed. The time course of 
classical pathway fixation by these synthetic oligomers 
indicates that some of the components preceding C3 in the 
cascade are being enzymatically degraded. Monovalent antigen 
did not alter the fixation of either pathway by these 
synthetic oligomers of IgG. 
1 
CHAPTER 1 
Survey of Research on the Mechanism 
of Complement Activation 
Complement is a system of proteins in serum which, 
when activated, performs various biological functions such 
as cell lysis, opsinization, vasodilation and chemotaxis. 
The classical pathway of complement activation begins with 
the association of immunoglobulins, either IgM or IgG, 
to cell surfaces or soluble antigens. Cl is then bound 
and activated by these immunoglobulin aggregates and the 
cascade is initiated by the proteolytic cleavage of C4 
by Cl and the subsequent formation of a c14b 2a complex 
after the cleavage of C2. The active complex C~, 
termed C3 convertase, cleaves C3 forming a c4b 2a 3b 
complex which activates CS also by a proteolytic cleavage. 
No further protease activity appears to be necessary for 
the completion of activation, but the self-assembly of 
c 5b 6789 on the cell surface completes the cytolytic 
structure (Porter and Reid, 1979). 
An alternative pathway to complement activation uses 
a different set of initiating proteins and enzymes, called 
the properdin system, to achieve the activation of C3 but 
from that point on the classical and alternate pathways 
are coincident. The alternate pathway achieves activation 
in the absence of immunoglobulin, Cl, C2, and C4 (Gotze 
and Muller-Eberhard, 1976). 
2 
The present experimental evidence indicates that a 
minimum of two juxtaposed antibody molecules is required 
for complement activation either on the cell surface 
(Borsos and Rapp, 1965) or in solution (Cohen, 1968; 
and Wright et aZ., 1980). The interaction of immuno-
globulin aggregates with Cl is through Clq,a 410,000 
dalton protein which appears to possess six sites with 
affinity for immunoglobulins (Reid and Porter, 1976). 
The binding site for Clq on IgG appears to be in the 
CH 2 domain (Yasmeen et al., 1976) but the amino acid 
residues forming the site have not been determined. 
Allan and Isliker (1974) have used chemical modification 
techniques to demonstrate the involvement of tryptophan 
277 in complement activation; moreover, binding studies 
of synthetic (Johnson and Thames, 1976) and natural 
polypeptides (Lee and Painter, 1980) which duplicate the 
CH 2 region in the vi~inity of tryptophan 277 indicate 
the location of the Clq binding site is in this region. 
However, others have proposed the basic region at the 
carboxyl end of the CH 2 domain as the Clq binding site 
(Burton et al., 1980). They base their proposed site on 
three factors: (1) availability for binding, (2) genetic 
conservation of amino acid residues between domains, and 
(3) the fact that polyionic molecules are capable of 
activating complement via Cl. 
One model for the interaction of immunoglobulin with 
Cl delineated by Hoffmann (1976a,b,c) considers Clq to be 
3 
the substrate of an allosteric protein, immunoglobulin, 
while antigen acts as an allosteric regulator. In this 
model the immunoglobulin is in equilibrium between a 
relaxed and a tensed state; the relaxed state must be 
achieved for complement activation to occur. In the 
Hoffmann model the protomer, the functional regulatory-
catalytic unit, is the heavy-light chain structure. The 
ratio of molecules in the tensed state to molecules in the 
relaxed state in the absence of antigen or Clq is: 
( 1) 
Each state, R and T, has a specific dissociation constant 
for both types of ligands. Initially treating every 
component as univalent for mathematical simplicity, 










< 1 ( 3) 
The affinity of immunoglobulins for Clq is also assumed 
to be greater in the R state than in the T state. In the 
presence of saturating amounts of antigenic ligand the 
ratio of the number of molecules in the T state to the 
number of molecules in the R state is given as: 
4 
L' = L (KRA)N 
o KTA 
(4) 
where N is the number of protomers acting concertedly. 
One assertion made by Hoffmann is that native IgG has 
two protomers but when aggregated by antigen the number 
of protomers is twice the number of IgG molecules in the 
aggregate. This requires that the IgG molecules in the 
aggregate act in concert allosterically; that is to say, 
they act cooperatively in their transition from the T 
state to the R state. 
The initial motivation for the development of this 
model came from the observation of cooperativity in the 
binding of Cl to dinitrophenylated erythrocytes covered 
with antibody (Thompson and Hoffmann, 1974a,b). Although 
some objection has been made to the experimental procedure 
(Metzger, 1978), this cooperativity is a direct indication 
of the allosteric nature of the protein. 
Experimental evidence frequently cited in support of 
the allosteric model is the activation of complement by 
IgM which had bound monovalent antigen (Brown and Koshland, 
1975). IgM specifically against p-(p-dimethylaminobenzeneazo)-
phenyl-8-lactoside (Lac dye) was used to activate complement 
but monovalent antigen caused the anti-Lac IgM to activate 
complement without observable aggregation of IgM. Further-
more this complement fixation could be inhibited by the 
hapten. The authors interpreted these results as reflecting 
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a conformational change in the Fe region of IgM which 
alters the functional properties of the immunoglobulin. 
The authors interpreted the smaller binding constant for 
monovalent antigen as compared to hapten in terms of the 
thermodynamic coupling of binding antigen and changing 
conformation. In this scheme, some of the free energy 
evolved when antigen is bound is coupled to the confer-
mational change of the immunoglobulin which presumably 
has a positive free energy term. The summation of the two 
steps leads to a less negative free energy for the overall 
reaction and, therefore, a smaller binding constant. 
Metzger (1978) points out that this need not be the case 
because the bulk of the monovalent antigen may simply give 
it less affinity for the IgM than the hapten. 
The results of Brown and Koshland are readily inter-
pretable in terms of the model of Hoffmann. The discrim-
ination between hapten and monovalent antigen on the basis 
of complement activation may be related to the difference 
in the association constants in the T and R states for the 
particular ligand. As seen in equation 4 the only difference 
in L' between saturating hapten and saturating monovalent 
K . h antigen will come from the quantity ( RA/KTA), because t e 
number of associated protomers, N, and the state of the 
equilibrium in the absence of ligand, L , will be unchanged. 
0 
The agreement of the complement fixation results with the 
allosteric model only requires that KRA/KTA for the 
K 
monovalent antigen be significantly less than RA/KTA 
6 
for the hapten. If one assumes the values used by 
Hoffmann (1976a), then this decrease must be on the 
order of SO%. 
Several techniques have been used to observe confor-
mational changes in the Fe portion of IgG upon binding 
antigen. Schlessinger e t a l. ( 19 7 5) used circularly 
polarized fluorescence to monitor conformational changes 
in IgG. The systems under study included: (1) a hapten-
like tetra-D-alanine with anti-poly-D-alanine IgG, 
(2) the multivalent antigen RNase with anti-RNase IgG, 
and (3) the monovalent hapten, lysozyme "loop" peptide, 
with anti-"loop" IgG. Both the monovalent and multivalent 
antigens caused changes in the circularly polarized 
fluorescence spectra of their respective IgG when bound, 
but tetra-D-alanine did not. These spectral changes were 
interpreted as reflecting conformational changes in the 
immunoglobulin. The changes observed when Fab bound antigen 
did not fully account for the changes observed in the entire 
immunoglobulin so that some of the spectroscopic difference 
between changes in the spectrum of whole immunoglobulin 
and the spectrum of Fab were attributed by the authors to 
changes in the Fe region. This work assumed that spectro-
scopic alterations arising from the enzymatic digestion used 
to produce Fab would be negligible. When the disulfide 
bonds of the IgG were reduced and alkylated the spectro-
scopic changes in IgG resulting from antigen being bound 
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resembled those changes in Fab. The reduction of 
disulfide bonds had been previously shown to reduce 
complement activation significantly (Schur and Christian, 
1964; Press, 1975) so that the elimination of spectro-
scopic changes by a process which reduces complement 
activation was used to demonstrate a link between the 
spectroscopic observation and effector function. 
Henney and Ishizaka (1968) found the appearance of 
new antigenic determinants in the Fe region of IgG in 
antigen-antibody aggregates which were not apparent in 
free IgG. These uncovered determinants showed cross-
reactivity with the Fe region of IgG aggregates produced 
by heat or ethanolic denaturation. The appearance of new 
antigenic determinants was attributed to a conformational 
change in the Fe region and the cross-reactivity indicated 
to the authors that similar conformational changes occur 
in the process of denaturation, thus enabling antigen-free 
aggregates of IgG to fix complement. However it can be 
argued that antigen and Fe in close proximity, which may be 
the case for antigen-antibody aggregates, act together to 
form a new antigenic determinant. 
Additional evidence for a conformational change 
occurring in the Fe region of IgG upon antigen binding is 
the appearance of previously unexposed Protein A binding 
sites on rabbit IgG when antigen is present (Mota et al. , 
1981). Protein A from Staphylococcus aureus (SpA) binds 
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in the region where the CH 2 domain attaches to the CH 3 
domain (Deisenhofer et al., 1978). Mota and his coworkers 
found that rabbit, anti-ferritin IgG formed the stable 
complex (IgG2SpA1 ) 2 ; this complex could bind a small 
fragment of Protein A, fSpA, but was not retained on an 
affinity column consisting of Protein A covalently linked 
to sepharose. However, when the (IgG 2-spA1 ) 2 complexes 
were reacted with an excess of ferritin to give (IgG2-
SpA1)2· (ferritin), the complexes were retained on the 
affinity column. The authors argue that this retention 
is the result of exposure of a binding site for Protein A 
upon binding antigen which had previously been buried. 
If the binding of Clq were analogous, then binding 
antigen might expose sites for Cl which had previously 
been buried. 
Aggregates of IgG produced by denaturation (Ishizaka 
and Ishizaka, 1960) and chemical crosslinking (Ishizaka 
et al., 1967; Wright et al., 1980) appear to fix complement 
by the classical pathway. Augener e t al. (1971) have shown 
Cl binding by aggregates of Fe from IgG to be nearly as 
efficient as aggregates of whole IgG. This ability to 
fix complement by IgG aggregates produced by such diverse 
means has given rise to the aggregation theory of complement 
activation which, in its simplest form, states that antigen 
serves to aggregate IgG and aggregation increases the 
avidity of Clq for IgG by overcoming the entropy involved 
in sequentially binding free molecules from solution. A 
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more refined model has been proposed by Metzger (1974) 
which assumes multiple Clq binding sites on IgG and 
suggests that the cooperativity observed by Thompson and 
Hoffmann (1974a,b) results from these sites being 
stabilized by the initial binding of Clq to the antigen-
antibody aggregate and eventually being bound by other 
Clq's giving rise to an activating aggregate comprised of 
multiple Cl's. 
The analysis of fluorescence depolarization and 
X-ray crystal data (McCammon and Karplus, 1977) indicates 
a great deal of flexibility of the Fab arms of IgG with 
respect to the Fe region. The interpretation of X-ray 
data from IgGDob (Silverton et aZ.~ 1977) finds little 
interaction between CH1 and CH 2 regions on the same heavy 
chain. These two aspects of IgG structure, flexibility 
and transdomain isolation, support the aggregation theory 
by denying a physical · mechansim by which changes in 
occupation of the binding site are transmitted to the Fe 
region. However, other researchers (Huber et aZ.~ 1976) 
have speculated that such flexibility between CH1 and CH 2 
diminishes by the constriction of the hinge region when 
antigen is bound,thereby providing an avenue for transmission 
of information about the occupation of the binding site by 
antigen. 
While studies using circularly polarized luminescence 
have found spectral changes attributed to antigen binding, 
10 
other techniques have found no such dependence. These include 
NMR studies of gadolinium III interacting with rabbit IgG 
(Dower et al., 1975) and ESR studies of spin labels 
attached to the carbohydrate of CH2 (Willan et al., 1977). 
The latter experiment seems particularly relevant to 
complement fixation because the oligosaccharide found in 
the CH 2 domain of IgG seems to be involved in the 
activation of Cl. 
The dependence of chemical and enzymatic reactivity 
of IgG on the presence of bound antigen has also been 
examined (Wright et al., 1978). Knowing the integrity of 
disulfide bonds in IgG was requisite for complement activation, 
these authors followed the kinetics of reduction of disulfide 
bonds between the heavy chains in the presence and absence 
of hapten and multivalent antigen. In neither case was the 
rate of reduction significantly altered by the presence of 
ligand. Similarly the rate of proteolytic cleavage of IgG 
by papain to give Fab and Fe fragments did not change when 
either hapten or multivalent antigen was bound. These 
negative results were interpreted as evidence against any 
significant conformational change occurring on the carboxyl 
side of the CH1 domain. One objection to this interpretation 
of the proteolytic observations is that alterations in the 
rate of proteolysis will most likely arise from effects on 
the rate limiting step of the process. If the rate limiting 
step for proteolysis is independent of the conformation of 
the IgG then the overall rate will probably not reflect 
11 
conformational changes in IgG. Furthermore recent work on 
the effect of reduction of IgG on its ability to activate 
complement implicated intrachain disulfide bonds as being 
crucial for the activation of complement instead of those 
disulfide bonds between heavy chains (Johnson and Hoffmann, 
1981). Thus the kinetics of the reduction of inter-heavy 
chain disulfide bonds may not be directly relevant to 
complement activation. 
While the aggregation theory has an appealing simpli-
city, it cannot account for all the experimental observations 
concerning the cooperativity of cl binding and the acti-
vation of complement by (Lac1-RNase•IgM). At the same 
time conformational changes attributed to antigen binding 
have not been unambiguously assigned to the Fe region of 
IgG. Furthermore, the evidence for activation of complement 
by antibody aggregates in the absence of any antigen appears 
to obviate the need for any binding of an antigenic ligand. 
The work presented in this thesis will focus on the obser-
vation of conformational changes resulting from antigen 
binding, the assignment of these changes to the Fe region, 
and the differences existing between complement activation 
by IgG-antigen aggregates and complement activation by 
aggregates produced by chemically crosslinking IgG. 
12 
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CHAPTER 2 
The Synthesis and Reactivity of a 
Modified Koshland's Reagent 
INTRODUCTION 
Horton and Koshland (1965) developed a chemical 
reagent, 2-hydroxy-5-nitrobenzyl bromide, which showed great 
selectivity among naturally occurring amino acids for 
tryptophan. This reagent has subsequently been used to 
examine the role of tryptophan in such proteins as pepsin 
(Dopheide and Jones, 1968), chymotrypsin (Oza and Martin, 
1967), and immunoglobulin G (Allan and Isliker, 1974). 
Because of the unique spectral properties of the hydroxy-
nitrobenzyl group in the visible region at high pH, it has 
been used as a facile means of quantifying tryptophan in 
proteins (Barman and Koshland, 1967). 
The sulfoniurn salt of this benzyl bromide was found 
to retain the specificity for tryptophan which the original 
Koshland's reagent possessed and additionally had a number 
of useful qualities not found in the earlier reagent 
(Horton and Tucker, 1970). The dimethyl (2-hydroxy-5-
nitrobenzyl) sulfonium bromide was more soluble and more 
stable in aqueous solutions than its corresponding benzyl 
bromide. This allowed for the preparation of reagents in 
aqueous solutions and decreased the molar excess of reagent 
needed to derivatize the same number of tryptophan residues. 
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Another analog of Koshland's reagent was the 2-methoxy-
5-nitrobenzyl bromide, but it was found that this reagent 
lost much of its specificity for tryptophan; which led 
to the conclusion that a hydroxyl group ortho to the 
bromornethyl group was necessary for the reagent's 
specificity (Horton et al., 1965). 
Some of the reaction products of Koshland's reagent 
and the sulfonium salt of this reagent with tryptophan 
ethyl esters have been isolated and characterized (Loudon 
and Koshland, 1970). There appeared to be at least two 
monosubstituted and two disubstituted derivatives with the 
possibility of acid catalyzed rearrangement of the mono-
substituted forms (Figure 1). This study indicated that 
the selectivity of Koshland's reagent arises from two 
properties: (1) the hydrophobic nature of the reagent 
and (2) the ability of nitrobenzene compounds to form 
charge-transfer complexes with tryptophan. 
This chapter details the synthesis, purification and 
characterization of a modified Koshland's reagent, dimethyl 
This (2-hydroxy-3-methyl-5-nitrobenzyl) sulfonium bromide. 
reagent was developed to incorporate 3H and 14c in a 
tryptophan-specific reagent. The incorporation of radio-
isotopes allows for the detection of reagent at lower levels 
and with greater accuracy than spectroscopy because of the 
difficulties in quantitating the extent of reaction caused 
by perturbations in the spectra of the derivatized protein 
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arising from benzylation of the tryptophan residues (Horton 
and Koshland, 1967). The use of two distinguishable radio-
isotopes makes double radiolabeling techniques possible 
(Kaplan, 1971). 
MATERIALS AND METHODS 
Dimethyl (2-hydro~y-3-methyl-5-nitrobenzyl) sulfonium bromide 
The synthetic route to dimethyl (2-hydroxy-3-methyl-
5-nitrobenzyl) sulfonium bromide (abbreviated HMNB-DMSBr) 
is diagrammed in Figure 2. Salicylaldehyde was reduced 
to 2-hydroxybenzyl alcohol using the procedure of Chaikin 
and Brown (1949). It was in this reduction that 3H was 
introduced. Tritiated NaBH4 (New England Nuclear, 100 mCi 
at 282 rnCi/mmol) was dissolved in 0.2 rnl of H2o;methanol 
(1:1, v:v) made 0.1 N in KOH. A solution of salicylaldehyde 
in the same solvent system was made up by dissolving 2 grams 
of salicylaldehyde in 2 ml of methanol and adding this 
dropwise to 6 ml of 0.1 N KOH in 1:1 H20/methanol. The 
tritiated NaBH 4 solution was placed in a 250 rnl round bottom 
flask and the salicylaldehyde in 0.1 N KOH was added dropwise 
with stirring. After 15 minutes a solution of nonradioactive 
NaBH
4 
(0.15 gm in 12 ml of 0.1 N KOH H2o;methanol) 
was 
added dropwise and the reaction stirred at ambient temperature 
for 24 hours producing 2-hydroxybenzyl alcohol. 
The alcohol was further reduced to a-cresol with 
Raney nickel catalyst (Papa et al., 1942). A 10% solution 
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of NaOH in H2o (50 ml) was added to the 2-hydroxybenzyl 
alcohol in the same 250 ml round bottom flask used in the 
borohydride reduction. The solution was heated to 90°C 
and 6 gm of Raney nickel catalyst was added in small portions 
with stirring over a period of 2.5 hours. Octyl alcohol 
was occasionally added to diminish foaming of the reaction 
mixture when the catalyst was added. The mixture was kept 
at 90°C for one hour after all the catalyst had been added 
and then it was allowed to cool to room temperature. The 
reaction mixture was then filtered and added dropwise to 
50 ml of 6 N HCl(aq)· The acidified solution was extracted 
twice with 30 ml of diethyl ether and the a-cresol was 
recovered after removal of the ether by rotary evaporation. 
Water (90 ml) was added to the a-cresol in a 250 ml round 
bottom flask and the solution cooled in an ice-water bath. 
The a-cresol was nitrated para to the hydroxy group 
(Clemence and Raiziss, 1934) by dissolving 1.65 gm of NaNo 2 
in the aqueous a-cresol solution and adding 10 ml of a 5% 
H2so4 (aq) solution with vigorous stirring while keeping the 
reaction mixture cold. The resulting 2-methyl-4-
nitrosophenol was oxidized with dilute HN0 3 (aq) and the 
crude 2-methyl-4-nitrophenol was recrystallized from 
hot H2o, filtered, and dissolved in 7 ml of 30% HBr(aq). 
Bromomethylation was executed following a published 
procedure (Buehler et al., 1967) using 0.5 gm of paraformalde-
hyde and 100 ~1 of concentrated H2so4 . The solution of 
2-methyl-4-nitrophenol with paraformaldehyde and H2so4 in 
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30% HBr(aq) was stirred for three hours. The solid product 
was collected by filtration, dissolved in dimethylsulfide, 
and, after 12 hours, the crude dimethyl (2-hydroxy-3-methyl-
5-nitrobenzyl) sulfonium bromide was collected by filtration. 
The product was recrystallized by dissolving the solid in a 
minimal amount of methanol at 45°C, cooling this solution to 
room temperature, adding diethyl ether until an initial 
precipitate formed and then cooling the mixture in an ice-
water bath. 
14 The synthesis of C HMNB-DMSBr began with the bromo-
methylation of 2-methyl-4-nitrophenol using 2 mCi of 14c 
paraforrnaldehyde (Arnersham. Searle Corp. , 250 mCi/grn) which 
was diluted with 94 mg of non-radioactive paraforrnaldehyde. 
Reaction of HMNB-DMSBr with Free Amino Acids 
The specificity of HMNB-DMSBr for tryptophan in solution 
of free amino acids was ascertained in the following manner. 
A solution of natural amino acids was made up in a 0.05 M 
NaH 2Po4 buffer at pH 6.8. All the amino acids were 1 x 10-
3
M. 
HMNB-DMSBr was added as a solid and in three trials, the 
-4 final HMNB-DMSBr concentrations were 9.4 x 10 M, 4.9 x 
10-3 -3 M, and 9.7 X 10 M. After the reactions were stirred 
at 4°C for 24 hours, 50 ~1 aliquots were analyzed on a 
Beckman 140B amino acid analyzer. 
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Reaction of HMNB-DMSBr with Reduced and Alkylated Chicken 
Lysozyme 
Chicken lysozyme (Grade I, Sigma Chemical Co.) was 
dissolved to 1 mg/ml in 0.10 M NaCl, 0.05 M tris buffer 
pH 8.0. A fivefold molar excess of dithiothreitol was 
added to the protein solution. After stirring at ambient 
temperature for two hours, the reduced protein was 
alkylated by adding a tenfold molar excess of iodoacetamide 
and gently agitating this reaction solution for 24 hours 
while protected from light. The reduced and alkylated 
chicken lysozyme was then dialyzed against 0.10 M NaCl, 
0.05 M NaH2Po4 , pH 6.8 and concentrated to 1 mg/ml by 
ultrafiltration. A tenfold molar excess of HMNB-DMSBr 
was added to the protein as a solid and the solution 
stirred for 24 hours at room temperature. The protein 
was then exhaustively dialyzed against 0.10 M tris buffer 
pH 8.0 at 4°C _to remove the benzyl alcohol produced by 
hydrolysis and then desalted by dialysis against H2o. 
Aliquots of 50 ~1 of 2.0 M mercaptoethane sulfonic acid 
(Pierce Chemical Co.) were added to the protein and the 
hydrolysis was performed under nitrogen at ll0°C for 
twelve hours. The acid was partially neutralized by the 
addition of 50 ~1 of 2 M NaOH(aq) and aliquots were 
analyzed as before. 
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Reaction of HMNB-DMSBr with Rabbit IgG 
Antibodies were raised in rabbits against pneumococci 
III bacteria to high titer and restricted heterogeneity 
using the innocculation regimen of Kimball et aZ. (1971). 
The IgG was isolated from serum by dialyzing 200 ml of 
serum against 0.1 M tris buffer pH 9.0 at 4°C and applying to 
a sephadex QAE-50 column (5 x 30 em) equilibrated with the 
tris buffer. All unbound protein was eluted with this 
starting buffer and the IgG was eluted with a linear ionic 
gradient formed by placing 0.3 M NaCl in 0.1 M tris pH 9.0 
in the static chamber and having 0.1 M tris pH 9.0 in the 
mixing chamber. The IgG was the first peak eluted. After 
concentrating the IgG peak by ultrafiltration, it was 
applied to a cibacron blue column (Pharmacia Fine Chemicals, 
Upsala, Sweden) and eluted with this saline-phosphate 
buffer. 
Either HNB-DMSBr or HHNB-DSMBr was added as a solid to 
a 1 mg/ml solution of rabbit IgG in 0.1 M NaCl, 0.05 M 
NaH 2Po4 pH 6.8, chilled in an ice-water bath until a 
fivefold molar excess of Koshland' s reagent was achieved. 
The reaction solution was gently agitated for 12 hours at 
4°C then exhaustively dialyzed against 0.05 M tris buffer 
pH 8.0. The protein concentration was assayed by the 
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. 1% a sorbance at 0 nm us1ng E1 em 
= 13.5 for rabbit IgG 
-1 -1 
(Stevenson and Darrington, .1970), £ = 18000 M em 
for the 2-hydroxy-5-nitrobenzyl moiety at pH > 10 (Horton 
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-1 -1 and Koshland, 1967) and £ = 17500 M em for the 2-
hydroxy-3-methyl-5-nitrobenzyl moiety at pH > 10. 
The digestion of derivatized IgG with pepsin and the 
separation of the peptic fragments were performed according 
to the procedure of Allan and Isliker (1974). 
Partition of HNB-OH and HMNB-OH between Diethyl Ether and 
Phosphate Buffer 
A basic solution (1 ml) of 14c-HMNB-DMSBr (0.0287 M) 
and HNB-DMSBr (0.0287 M) in 0.1 N NaOH was heated to 40°C for 
24 hours and then diluted with 25 ml of 0.5 M NaH2Po4 pH 6.8. 
Diethyl ether (25 ml) was added to the phosphate buffer 
solution in a 250 ml separatory funnel and this was 
agitated for 30 minutes at room temperature. The aqueous 
phase was collected; the ether phase was dried with 
Mgso4 (anh), the ether evaporated by gently heating under 
vacuum, and the residue was redissolved in 3 ml of the 
phosphate buffer. 
Liquid scintillation counting of samples from the 
aqueous and ether phases was performed on a Beckman LS-250 
liquid scintillation counter programmed for a 3% counting 
error. The samples were prepared by adding 10 ml of 
Aquasol 2 liquid scintillation fluid (New England Nuclear 
Inc.) to 1 ml of the phosphate buffered sample. 
Difference Spectra of HNB-OH and HMNB-OH with Tryptophan 
Difference spectra were obtained following the 
procedure of Loudon and Koshland (1970). The reagents 
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were dissolved in 0.1 M NaHco2 , pH 3.2 to a final concen-
tration of 3.0 x 10-4 M for 2-hydroxy-3-methyl-5-nitrobenzyl 
alcohol or 2.7 x 10-4 M for 2-hydroxy-5-nitrobenzyl alcohol. 
Then varying amounts of tryptophan were added to achieve 
a concentration range from 10 mM to 75 mM. The measurements 
of the change in absorbance were made at 380 nm at room 
temperature. A second series of measurements was made in 
0.1 M NaH 2Po4 , pH 6.8 using the same benzyl alcohol and 
tryptophan concentrations. 
RESULTS 
Synthesis of HMNB-DMSBr 
The NMR spectrum of 2-hydroxy-3-methyl-5-nitrobenzyl 
bromide, obtained from the bromomethylation of 2-methyl-4-
nitrophenol as described and prior to the addition of 
dimethyl sulfide, is ~hown in Figure 3. The spectrum 
was taken with a Varian EM-390 spectrometer using d 6-acetone 
as the solvent and TMS as the zero standard. 
The crystals of dimethyl (2-hydroxy-3-methyl-5-
nitrobenzyl) sulfonium bromide appeared as short, cream-
colored needles. The product decomposed at 156°C with the 
evolution of dimethyl sulfide. The calculated and observed 
values for the elemental analysis were respectively: 
C 38.97; H 4.58; N 4.54; 0 15,57; S 10.40; Br 25.93, and 
C 38.97; H 4.59; N 4.44; 0 15.38; S 9.50; Br 25.78. 
The tritiated, modified Koshland's reagent had a specific 
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activity of 18 ~Ci/mrnol and the 14c modified Koshland's 
reagent was 13 ~Ci/mmol. 
Reactivity of HMNB-DMSBr with Free Amino Acids 
Table 1 lists the results of studies on the reacti-
vities of various amino acids toward HMNB-DMSBr. The 
peak areas of the chromatograms and those areas normalized 
to the area of the alanine peak are given. At concen-
trations of reagent 5 to 10 times that of tryptophan, all 
of this amino acid was derivatized; the reagent did not 
attack any other amino acid with comparable vigor. The 
reactivity of dimethyl (2-hydroxy-5-nitrobenzyl) sulfonium 
bromide toward cysteine has been previously demonstrated 
(Horton and Tucker, 1970) and similar reactivity was found 
for the modified Koshland's reagent with cysteine. 
Reactivity of HMNB-DMSBr with Reduced and Alkylated Chicken 
Lysozyme 
When native chicken lysozyme is reacted with an excess 
of HMNB-DMSBr, the protein is highly derivatized and forms a 
precipitate. To avoid this problem the chicken lysozyme 
was completely reduced and alkylated prior to derivatization 
as described in Materials and Methods. 
After exhaustive dialysis the reduced and alkylated 
chicken lysozyme had incorporated 1.06 2-hydroxy-3-methyl-
5-nitrobenzyl moieties per molecule of protein. This was 
calculated using E
1
1 % = 24.7 at 280 nm for chicken lysozyme 
ern 
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(Davies et al., 1969). Table II gives the amino acid 
analysis for reduced and alkylated chicken lysozyme before 
and after derivatization with HMNB-DMSBr. The amino acid 
analysis shows 2.5 out of 3.3 or 76% of the recoverable 
tryptophan underivatized compared to 4.9 out of 6 or 82% 
of the tryptophan being unreacted as measured spectrophoto-
metrically for the whole, reduced and alkylated protein. 
It is also noteworthy that amino acids shown to be reactive 
with less selective benzyl halides, in particular, methionine, 
serine, and tyrosine (Horton and Koshland, 1967) were not 
measurably derivatized by this procedure. 
Reactivity of HMNB-DMSBR with Rabbit IgG 
The molar ratio of covalently linked 2-hydroxy-3-
methyl-5-nitrobenzyl moieties to IgG molecules was 0.41 with 
a standard deviation of 0.02, when labeled as described 
above, as compared to 0.60 for the (2-hydroxy-5-nitrobenzyl) 
IgG ratio under identical conditions. Unlike the tryptophan 
reactivity found in rabbit IgG benzylated with 2-hydroxy-
5-nitrobenzyl bromide (Allan and Isliker, 1974), tryptophan 
residues in both the Fab and Fe regions were derivatized. 
Figure 4 is the chromatograph of the peptic digest of labeled 
rabbit IgG on sephadex G-75, and the absorbances at 410 nm 
and 280 nm are shown. The distribution of label between 
Fab and Fe is approximately the same for HMNB-DMSBr and 
HNB-DMSBr. 
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Partition of HMNB-OH and HNB-OH between an Organic Phase 
and an Aqueous Phase 
After evaporating the ether, the mixture of 2-hydroxy-
3-methyl-5-nitrobenzyl alcohol and 2-hydroxy-5-nitrobenzyl 
alcohol from the organic phase has redissolved in 0.5 M 
NaH 2Po4 . One millilitre of this solution had 16627 cpm 
and, at pH > 10, an absorbance of 26.12 at 410 nm. One 
millilitre of the aqueous phase after the diethyl ether 
extraction had 233.2 cpm and, at pH > 10, an absorbance 
of 0.370. 
Association of HMNB-OH with Free Tryptophan in Solution 
Figure 5 shows the plot of -(ln ~ absorbance) versus 
-(ln[trp]) for the benzyl alcohols of Koshland's reagent 
and modified Koshland's reagent at pH 3.2. Linear 
regression of these data gives a slope of 1.063 for 
2-hydroxy-5-nitrobenzyl alcohol and 1.024 for 2-hydroxy-
3-methyl-5-nitrobenzyl alcohol with a correlation coefficient 
of 0.99. No evidence of complexation was observed at pH 6.8 
when difference spectra were taken from 340 nm to 
600 nm. 
DISCUSSION 
The modified Koshland's reagent, dimethyl (2-hydroxy-
3-methyl-5-nitrobenzyl) sulfonium bromide, appears to have 
the same selectivity for tryptophan that was observed for 
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the dimethyl sulfonium salt of the original reagent (Horton 
and Tucker, 1970). The similarity in reactivity is 
consistent with the similarity in hydrophobicity and 
electronic properties observed between 2-hydroxy-5-
nitrobenzyl alcohol and 2-hydroxy-3-methyl-5-nitrobenzyl 
alcohol in the partition experiments and visible spectra. 
Values for the cpm per absorbance unit in one millitre of 
sample were 638 for the organic phase and 630 for the 
aqueous phase. These results indicate that there is no 
significant difference in the partition coefficients of the 
alcohols in this system. The close agreement of the slopes 
for the plots of -ln(~ absorbance) versus -ln [trp] shows 
that the interaction of the alcohols with tryptophan in 
formate buffer is approximately the same. Loudon and 
Koshland (1970) have asserted that these two characteristics, 
hydrophobicity and charge-transfer interaction, lead to the 
specificity of Koshland's reagent for tryptophan. The 
absence of observable complexation at pH 6.8, the pH at 
which labeling with the modified Koshland's reagent is 
performed, may be due to the ionization of the phenol at 
this pH. The nitrophenolic anion, stabilized as shown in 
Figure 6 by the benzyl alcohol, would have less affinity 
for electron donation from tryptophan than the uncharged 
nitrophenol. The increased absorbance at 410 nm for the 
two benzyl alcohols at this pH indicated significant ioni-
zation which was not present at pH 3.2. 
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The quinone methide species has been postulated to 
explain the reactivity of HNB-DMSBr (Loudon and Koshland, 
1970) and similar resonance structures can be drawn for 
HMNB-DMSBr as shown in Figure 7. If the slight decrease 
in the reactivity of HMNB-DMSBr with rabbit IgG as compared 
to HNB-DMSBr with rabbit IgG cannot be attributed to 
differences in electronic or hydrophobic properties between 
the two reagents; then perhaps there is a small steric 
factor which arises from the methyl group ortho to the 
benzylating methylene. 
Despite its somewhat decreased reactivity, the modified 
Koshland's reagent, dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl) 
sulfonium bromide is a selective reagent for tryptophan and 
can readily be made radioactive with 3H and 14c. 
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Figure 1. Diastereomers of Tryptophan Ethyl Ester 
Monobenzylated with Dimethyl (2-hydroxy-5-nitrobenzyl) 
sulfonium bromide 





Figure 2. Synthetic Route from Salicylaldehyde to 
Dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl) sulfonium 
bromide 
Tritium was incorporated in the initial reduction 
"th B Th . . f 14 d . th w1 Na H4 . e 1ncorporat1on o C occurre 1n e 
bromomethylation of 2-methyl-4-nitrophenol with para-










Figure 3. NMR Spectrum of 2-hydroxy-3-methyl-5-
nitrobenzyl bromide 
This spectrum was taken in d 6-acetone. The TMS 
peak and d 6-acetone peaks occur at o = 0 and o = 2.1 ppm 
respectively. The methyl protons have a downfield shift 
of 2.3 ppm and the methylene protons have a downfield 
shift of 4.7 ppm. Peaks for the aromatic protons are 

























Figure 4. Chromatograph of Papain Digestion Fragments 
from Rabbit IgG 
The protein was chrornatographed on sephadex 
G-75 (2.5 x 90 ern) and eluted with 0.01 M NaH 2Po4 , 
pH 8.5. The left axis of ordinates is the absorbance 
at 280 nrn (---),the right axis of ordinates is the 
absorbance at 410 nrn (~) , and the abscissa is the 
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Figure 5. Plot of -[ln(6 absorbance)] versus 
-[ln(trp]] for 2-hydroxy-3-methyl-5-nitrobenzyl 
alcohol and 2-hydroxy-5-nitrobenzyl alcohol 
The change in absorbance was measured at 380 nm 
with the particular benzyl alcohol under study as the 
reference. The 2-hydroxy-3-methyl-5-nitrobenzyl 
alcohol was 3.0 x 10-4 M (o) and the 2-hydroxy-5-
nitrobenzyl alcohol was 2.7 x 10-4 M (V). Both benzyl 
alcohols were in 0.1 M NaHco2 , pH 3.2. Linear 
regression gave a slope of 1.063 for 2-hydroxy-5-nitro-





















Nitrophenolic Anion of 2-hydroxy-5-nitrobenzyl 
This structure is proposed to account for the large 
degree of ionization observed for 2-hydroxy-5-nitrobenzyl 
























Figure 7. Quinone Methide Species for Dimethyl 
(2-hydroxy-5-nitrobenzyl) sulfonium bromide and 
Dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl) sulfonium 
bromide 
The structure proposed by Loudon and Koshland 
(1970) for the sulfonium salt of Koshland's reagent 
(above) can be applied to the modified Koshland's 
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Table I. Analysis of Labeled Free Amino Acid Solution ----
Amino 
0.0 mM HMNB-DMSBr 0.97 rnM HMNB-DMSBr 4.9 rnM HMNB-DMSBr 9.7 mM HMNB-DMSBr 
Acid peak normalized peak normal1zed peak normalized peak normalized 
area area a area area area area area area 
ala 4.37 1 7.11 1 4.12 1 5.16 1 
thr 8.31 1.90 12.4 1.74 7.53 1.83 9.04 1.75 
tyr 6.82 1.56 8.34 1.17 5.79 1.40 6.56 1.27 
phe 5.63 1.28 8.02 1.13 5.58 1.35 6.10 1.18 
his 3.57 .817 5.03 .707 2.37 .575 3.88 .752 
~ 
lys 2.66 .609 4.13 .581 2.53 .614 3.40 .659 
Ul 
arg 2.77 .634 4.45 .626 2.74 .665 3.56 .690 
trp 3.45 .802 1.91 .269 -0- -0- -0- -0-
--
aNormalized area refers to the peak area expressed in units of the alanine peak area 
for a particular HMNB-DMSBr concentration. 
Table II. Amino Acid Analysis of Labeled Chicken Lysozyme 
amino known 
a unlabeled, reduced and labeled, reduced and 
acid composition alkylated lysozyme alkylated lysozyme 
ala 12 12.1 12.1 
arg 11 7.2 6.9 
glx 5 6.1 5.9 
gly 12 12.6 13.5 
his 1 .83 1.1 
ile 6 5.4 5.4 
leu 8 10.1 9.3 
lys 6 4.2 3.9 ~ 0'\ 
met 2 1.7 1.7 
phe 3 3.3 3.1 
ser 10 10.0 10.0 
thr 7 6.1 6.6 
trp 6 3.3 2.5 
tyr 3 3.6 3.7 
val 6 5.9 5.7 
acomposition given by Canfield (1963). 
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CHAPTER 3 
The Dependence of the Reactivity of Tryptophan in 
IgG with HMNB-DMSBr on the Presence of Antigen 
As stated in the first chapter, two mechanistic models 
have been proposed for the activation of the classical 
pathway for complement fixation by IgG: an associative 
and an allosteric model. Much of the rebuttal made 
against evidence for the allosteric model arises from the 
inability of current data to ascribe a conformational 
change to the Fe region of IgG (Metzger, 1974; 1978). 
Many of the supportive spectroscopic studies do not observe 
the Fe region directly but draw conclusions from the 
comparison of the whole immunoglobulin to Fab. Also, 
the studies showing the appearance of new antigenic deter-
minants in the Fe region upon binding antigen do not 
adequately deal with the antigen's role in presentation 
of the determinant to the B cell which makes the immuno-
globulin. 
This chapter will describe a double radiolabeling 
technique to measure changes, upon binding antigen, in 
reactivity of Fe tryptophan residues toward the tryptophan 
specific reagent, dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl) 
sulfonium bromide [HMNB-DMSBr]. Observing tryptophan 
reactivities was first suggested by the work of Allan 
and Isliker (1974) which found that the modification of 
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two tryptophan residues in the Fe region of rabbit IgG 
severely attenuated the ability of aggregates of the 
immunoglobulin to fix complement. Tryptophan has also 
been shown to be necessary for polypeptides from the CH2 
domain to interact with Clq (Johnson and Thames, 1976; 
Lee and Painter, 1980). Finally the data from circularly 
polarized luminescence supporting conformational changes 
in actuality reflect the changes in the environments of 
tryptophan residues (Schlessinger et aZ., 1975). The 
CPL technique irradiates the sample at the absorption 
maxima of tryptophan and it is primarily this amino acid 
which fluoresces and is observed. 
The double radiolabeling technique begins by reacting 
the tritiated reagent with immunoglobulin in the presence 
or in the absence of ligand. After all the tritiated 
reagent has been consumed in the process of benzylating 
tryptophan or by hydrolysis with water, addition of 
identical amounts of immunoglobulin derivatized under 
control conditions with 14c HMNB-DMSBr provides an isotopic 
counting baseline so that from this point forward the 
3H: 14c ratio does not change. Then, after separation of 
Fab from Fe, the degree of tritium incorporation under 
the two conditions can be assayed by determining the 
relative 3H: 14c ratios in the intact antibody and Fab and 
Fe fragments. 
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MATERIALS AND METHODS 
Dimethyl (2-hydroxy-3-methyl-5-nitrobenzyl) sulfonium bromide 
Tritiated and 14c dimethyl (2-hydroxy-3-methyl-5-
nitrobenzyl) sulfonium bromide were synthesized and purified 
as described in Chapter 2. 
Isolation of UPC-10 IgG 
UPC-10 ascites produced in BALBc mice was centrifuged 
at 8000 x g for one hour to remove any debris. An 
ammonium sulfate precipitation was performed at room 
temperature by the slow, dropwise addition of a saturated 
ammonium sulfate solution (pH 7.4) to the stirring ascites 
until the final solution was at 45% saturation. The 
precipitate was stirred for 12 hours at room temperature 
and after pelleting by centrifugation, the precipitate 
was redissolved in 0.15 M NaCl, 0.02 M NaH 2Po4 , pH 7.4 
buffer. All subsequent purification steps were performed 
at 4°C. The protein solution was passed through a cibacron-
blue column (Pharmacia Fine Chemicals, Upsala, Sweden) 
eluting with 0.15 M NaCl, 0.02 M NaH 2Po4 pH 7.4 buffer. 
The eluted protein was concentrated by ultrafiltration, 
dialyzed against 0.10 M tris buffer pH 7.4 and applied to 
a sephadex QAE-50 column (5.0 x 33 em) previously 
equilibrated with the tris buffer. After eluting all 
unbound protein with this buffer, a linear, ionic gradient 
was used to elute the immunoglobulin. The static chamber 
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contained 500 ml of 2.0 M NaCl, 0.1 M tris, pH 7.4 buffer 
and the mixing chamber contained 500 ml of 0.10 M tris with 
pH 7.4 buffer. UPC-10 IgG was the first peak eluted by the 
gradient with an absorbance at 280 nm. 
Isolation of 29Bl IgG 
The mouse hybridorna 29Bl which produces an anti-
dinitrophenyl IgG 2a (Oi and Herzenberg, 1979) was produced 
as ascites in SJL x BALBc mice. The ascites fluid was 
precipitated and the precipitate collected in the same 
manner as for UPC-10 IgG. Then the precipitate was 
redissolved in a minimum of 0.05 M tris buffer pH 8.3 
and applied to a Whatman DE-sephacel column which had been 
equilibrated in this buffer. After eluting all unbound 
protein, a linear ionic gradient was used to elute the 
immunoglobulin. The static chamber contained 500 ml of 
0.5 M NaCl in 0.05 M tris buffer, pH 8.3. The first peak 
with an absorbance at 280 nm was pooled as the IgG. This 
peak was concentrated by ultrafiltration, dialyzed 
against 0.15 M NaCl, 0.02 M NaH 2Po4 , pH 7.4 buffer and 
chromatographed on LKB Ultragel AcA 34 (2.5 x 100 ern ) 
eluting with this saline-phosphate buffer. 
Reduction and Alkylation of UPC-10 and 29Bl IgG 
A one mg/ml solution of IgG in 0.10 M tris, 0.002 M 
EDTA pH 8.0 was made 0.65 mM in dithiothreitol and gently 
shaken for one hour at room temperature. Then sufficient 
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iodoacetamide was added to achieve a final iodoacetamide 
concentration of 6.0 mM. The solution was shaken for 12 
hours at room temperature in the dark. The protein was 
then dialyzed against 0.10 M NaCl, 0.05 M NaH2Po4 , pH 6.8 
buffer. The avidity of reduced and alkylated UPC-10 IgG 
for bacterial levan antigen was compared to native 
UPC-10 IgG in the following manner. Aliquots of 25 ~1 
of 8.5 mg/ml UPC-10 IgG or reduced and alkylated UPC-10 
IgG in 0.10 M NaCl, 0.05 M NaH2Po4 , pH 6.8 buffer were 
placed in microtest tubes. Then 75 ~1 of a 1.0 mg/ml 
bacterial levan solution in the same saline-phosphate 
buffer were added. The solutions were vortexed and stored 
at 4°C for 24 hours. The resulting precipitate was 
centrifuged for 30 minutes at 5000 x g and washed four 
times with cold phosphate buffer. The precipitate was 
redissolved in 1 ml of 0.1 N NaOH and quantified by the 
absorbance at 280 nm. . The avidity of reduced and alkylated 
29Bl IgG for dinitrophenyl moieties was assured by the 
retention of the protein on a DNP-sepharose column eluted 
with 0.10 M NaCl, 0.05 M NaH2Po4 , pH 7.4 buffer (Goetzl 
and Metzger, 1970). 
Synthesis of DNP-antigens 
DNP-glycine was synthesized according to the procedure 
of Porter (1950). 
The synthesis of DNP1-cytochrome C began with the 
chromatographic purification of horse heart cytochrome C 
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(Sigma Chemical Co.) by dissolving the protein to a 
concentration of 10 mg/rnl in 0.05 M NaH2Po4 , pH 6.8 and 
chrornatographing on sephadex G-75 (2.5 x 100 ern) eluting 
with this phosphate buffer. The cytochrome C peak was 
diluted to a concentration of l rng/ml and reacted with a 
100-fold excess of freshly recrystalized Koshland's reagent 
(Aldrich Chemical Co.). After dialyzing in 0.10 M tris 
pH 8.0, the nitro group was reduced to an amine by making 
the solution 50 rnM in Na2s 2o 4 . The protein was 
dialyzed against 0.05 M NaH2Po4 , pH 6.3 and a tenfold 
molar excess of dinitrofluorobenzene was added as a solid 
and the solution was stirred at room temperature for 
eight hours. The excess reagent was separated from the 
protein by chromatography on sephadex G-25 (2.5 x 30 ern) 
in the 6.3 buffer. The pH of the protein solution was 
adjusted to 7.4 and the protein concentrated by ultra-
filtration. The anti-DNP protein ABPC-22 IgM (Jarvis and 
Voss, 1981) was coupled to sepharose-4B by the method of 
Porath et al. (1973) and used for affinity chromatography 
of the DNP
1
-cytochrorne C. The purified protein was desalted, 
lyophilized, and stored at -20°C. 
DNP
30
-BSA was synthesized by dissolving 1 grn of BSA 
(Sigma Chemical Co.) in 10% NaHco 3 and adding 300 rng of 
dinitrofluorobenzene (Aldrich Chemical Co.). This was 
stirred at room temperature while protected from light, 
dialyzed against H2o, and lyophilized. The extent of 
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dinitrophenyl incorporation was quantitated using E1
1 % = ern 
6.1 at 280 nrn for BSA (Berrens and Bleurnink, 1965) and 
E = 16000 at 365 nrn for DNP. 
Determination of Binding Constant for DNP 1 -cytochrome C 
Tritiated DNP 1-cytochrome C was synthesized as 
described above using tritiated dinitrofluorobenzene 
(Amersharn Radiochernicals) diluted with nonradioactive 
dinitrofluorobenzene to an activity of 73 mCi/mmol. 
The resulting monovalent DNP 1-cytochrorne C had an 
activity of 61 rnCi/mmol. This radiolabeled, monovalent 
antigen was used to determine the binding constant of 
DNP 1-cytochrorne C with 29Bl IgG by the method of Hummel 
and Dreyer (1962). A sephadex G-75 column (1 x 40 ern) was 
equilibrated with a solution of 1.56 x 10-5M 3H-DNP 1 -
cytochrorne C in 0.15 M NaCl, 0.02 M NaH 2Po4 , pH 6.8 buffer. 
Then 0.5 rnl aliquots of 29Bl IgG at a concentration of 
-5 6.7 x 10 M were applied to the column at room temperature 
and 1.1 rnl effluent fractions were collected. One rnl was 
taken from each fraction, diluted with 10 rnl of Aquasol 2 
liquid scintillation fluid (New England Nuclear Radio-
chemicals) and counted. Then the absorbance at 280 nrn was 
measured to determine the protein concentrations in each 
fraction. The concentration of bound DNP 1-cytochrorne C, 
29Bl IgG, and free DNP 1-cytochrorne C was thus determined 
and an association constant calculated. 
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Isolation of Bacterial Levan from Aerobacter Zevanicum 
Aerobacter Zevanicum (ATCC strain 15552) was grown 
by initially innoculating 200 rnl of media composed of 
0.8% nutrient broth (Difco) and 6% sucrose. After three 
days of growth at 28°C, 18 liter bottles were innoculated 
with the 200 rnl cultures. The bacteria were killed after 
eight days of growth by adding 36 grn of NaN3 to the 18 
liter cultures. Cell debris was removed from the media by 
continuous flow centrifugation. The following procedure 
was used for isolation from two liters of this effluent. 
The effluent was heated to 95°C, then 50 ml of 0.5 M NaOH 
and 100 rnl of 10% Cdso4 in water were added. After cooling 
to room temperature the precipitate was removed by centri-
fugation at 1200 x g for three hours. The supernatant was 
then passed through a Mallinckrodt MB-3 column (2.5 x 50 ern) 
and concentrated to 400 ml by rotary evaporation. Then 
80 ml of choloroform and 16 ml of !-butanol were added to 
400 rnl of concentrated supernatant and the mixture was 
vigorously shaken for 30 minutes. After centrifuging the 
mixture at 8000 x g for 30 minutes, the aqueous phase was 
retained; care was taken to avoid any of the precipitate 
which formed at the interface. The chloroform/butanol 
precipitation was repeated until no precipitate formed. 
The aqueous solution was decolorized with activated charcoal 
and then added dropwise to four liters of rapidly stirring 
ethanol. The precipitate was isolated by centrifugation at 
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8000 x g for 10 minutes and dissolved in a minimal amount 
of 0.10 M tris base pH 8.5 and passed through a QAE-50 
column (5.0 x 25 em) equilibrated with this tris buffer. 
The polysaccharide was desalted by dialysis and lyophilized. 
Labeling of Immunoglobulins with HMNB-DMSBr 
The 29Bl IgG2a was labeled in the presence of hapten 
or monovalent antigen by first dissolving 1.85 mg DNP-
glycine or 41.3 mg DNP1-cytochrome C in 4 ml of 0.15 M 
NaCl, 0.02 M NaH 2Po4 , pH 6.8 buffer. Then 1 ml of a 
5 mg/ml solution of 29Bl IgG in this phosphate-saline 
buffer was added. The hapten control was run with 0.5 mg 
of glycine instead of DNP-glycine in the labeling buffer 
and the monovalent antigen control had 41.3 mg of cytochrome 
C which had been treated with Koshland's reagent as in the 
synthesis of DNP1 -cytochrome C instead of monovalent 
antigen in the solution. Freshly recrystallized tritiated 
-4 -3 HMNB-DMSBr (approximately 4 x 10 Min 1 x 10 N HCl(aq)) 
was added dropwise to the stirring protein solution at 
0°C until a sixfold molar excess of reagent to immuno-
globulin had been achieved. The labeling solution was 
then gently agitated at 4°C for 24 hours. After the labeling 
was complete, 5 mg of IgG, previously labeled in a manner 
identical to the 3H labeling procedure in the absence of 
ligand except using 14c HMNB-DMSBr, was added to each 
tritium reaction solution. This 3H-14c labeled antibody 
solution was then exhaustively dialyzed against 0.10 M tris 
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buffer pH 8.0. Then 30 mg of unlabeled IgG in 0.10 M 
tris buffer pH 8.0 was added as protein carrier. Two 
reactions were performed under each set of conditions 
using identical reagent solutions. 
The UPC-10 IgG was labeled at a lower concentration 
of immunoglobulin to allow the addition of a large amount 
of the multivalent antigen, levan. Labeling in the 
presence of multivalent antigen was performed by dissolving 
200 mg of levan in 35 ml of the phosphate-saline labeling 
buffer. Then 15 ml of a 0.33 mg/ml immunoglobulin solution 
was added dropwise with stirring at room temperature to 
prevent the formation of insoluble aggregates. The 
control solution labeled in the presence of multivalent 
antigen was UPC-10 IgG in labeling buffer. The rest of the 
procedure followed that used for 29Bl IgG. 
Separation of Antigens from Native or Reduced and Alkylated IgG 
Both DNP-glycine and DNP1-cytochrome C were separated 
from labeled 29Bl IgG by first dialyzing the protein against 
0.05 M tris buffer pH 8.0 and then making the solution 
0.03 Min Na2s 2o 4 by the addition of this salt as a solid. 
The solution was stirred for one hour at room temperature 
under N2 . Then o 2 was gently bubbled through the solution 
= The resulting for 30 minutes to remove any remaining s 2o 4 . 
diaminophenyl glycine was removed by dialysis against 
0.15 M NaCl, 0.02 M NaH 2Po4 , pH 7.4. The derivatized 
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cytochrome C was removed by chromatography on sephadex G-75 
(2.5 x 100 em) eluting with the same saline-phosphate 
buffer as for hapten. 
The levan/UPC-10 solutions were dialyzed against 8 M 
urea in 0.10 M tris buffer pH 8.0. These solutions were 
then applied to QAE-50 (2.5 x 30 em) previously equilibrated 
with the urea-tris buffer. After eluting with 500 ml of 
urea-tris buffer, thereby removing the levan, the column 
was equilibrated with 0.10 M tris pH 8.0 and the UPC-10 
IgG was then eluted with a linear ionic gradient as in the 
procedure for isolating the immunoglobulin. 
Papain digestion of Labeled, Native IgG and Labeled, Reduced 
and Alkylated IgG 
The IgG solutions were dialyzed against 0.05 M sodium 
acetate pH 5.5 and concentrated to 5 mg/ml by ultrafiltration. 
The protein was incub~ted with papain (Putnam et al. , 1962) 
at 37°C. An incubation period of 3 hours was used for 
UPC-10 IgG and 45 minutes for 29Bl IgG. 
Isolation of Fab and Fe Fragments from Papain Digestion of 
Labeled IgG 
The 29Bl fragments were separated by affinity chroma-
tography on a DNP-sepharose column as previously described. 
The Fe fragment was eluted in the void volume and the Fab 
fragment was eluted with 0.03 M DNP-glycine in the saline-
phosphate buffer. 
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The papain digest of UPC-10 IgG was concentrated by 
ultrafiltration and dialyzed against 0.05 M NaH 2Po4 , 
pH 6.6. Then the digest was chrornatographed on a Whatman 
DE-52 ion-exchange column (2.5 x 30 ern). The Fab fragment 
was eluted with the starting buffer and the Fe was eluted 
with a linear ionic gradient established by placing 
250 ml of 2.0 M NaCl, 0.05 M NaH 2Po4 , pH 6.6 buffer in the 
static flask and 250 ml of 0.05 M NaH2Po4 pH 6.6 buffer in 
the mixing flask. 
The purity of the protein fragments was checked by 
polyacrylamide gel electrophoresis. The identity of the 
Fe fragment was verified by its retention on Protein 
A-sepharose (Pharrnacia Fine Chemicals). 
Liquid Scintillation Counting Procedure 
The DNP-glycine was separated from 29Bl Fab fragments 
prior to counting as previously described. The Fab and Fe 
fragments were desalted by dialysis and concentrated to one 
ml by ultrafiltration. The concentrated Fab or Fe 
solutions were then added to 10 ml of Aquasol 2 liquid 
scintillation counting fluid. Experimental values were 
averages of duplicate countings on a Beckman LS-250 liquid 
scintillation counter programmed for a 3% counting error. 
All samples had counts greater than 10 times background. 
Complement Assay of Native or Reduced and Alklated IgG 
The complement assay was patterned after the micro-
complement assay of Bengali et al. (1980). The assay was 
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carried out in a Hepes buffer containing 0.1% gelatin and 
consisting of 0.01 M Hepes, 0.15 M NaCl, 0.00015 M Cacl 2 • 
2H2o, 0.0005 M MgC1 2 ·6H2o, pH 7.4. Initially the antigen-
antibody complex was incubated with two CH 50 units of 
guinea pig serum in 75 ~1 total volume in each well of a 
microtiter plate for 45 minutes at 37°C. Then 50 ~1 of a 
2% activated sheep erythrocyte cell suspension was added 
to each well and this was incubated for 45 minutes at 37°C. 
The microtiter plate was then centrifuged at 1000 x g for 
3 minutes at 4°C and 40 ~1 aliquots from each well were 
counted on a Beckman Gamma 4000 counter. Each condition 
was assayed in quadruplicate. A zero percent fixation 
control was run by incubating two CH50 units of guinea pig 
serum without any antibody or antigen and background for 100% 
fixation was determined from wells containing 75 ~1 of 
Hepes-gelatin buffer with no complement, antibody, or 
antigen. 
RESULTS 
Analysis of Monovalent Antigen 
Use of l-fluoro-2,4-dinitro(3,5- 3H) benzene (Amersham 
Radiochemicals) at a specific activity of 20.4 Ci/mmol of 
reagent allowed liquid scintillation counting to be used 
as an assay for DNP moieties; while the absorbance at 280 nm 
was used to determine the cytochrome C concentration (Mayer 
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and Miller, 1970). The number of DNP moieties incorporated 
per cytochrome C was 0.98 with a standard deviation of 0.02. 
An elution profile in counts per minute for tritiated 
cytochrome C off the sephadex G-75 column used for the 
Hummel-Dreyer measurement is shown in Figure 8. The 
association constant for DNP 1-cytochrome C with 29Bl IgG 
was Ka = 2.5 x 10 4 with a standard deviation of 1.4 x 10 4 
from five independent measurements. 
Separation of Fab and Fe Fragments after Papain Digestion 
of IgG 
Figures 9 and 10 show the chromatographic separation of 
the Fe and Fab fragments after papain digestion of radio-
labeled UPC-10 IgG and radiolabeled, reduced and alkylated 
UPC-10 IgG. The Fab fragment elutes first followed by the 
Fe fragment, which begins to elute at a conductivity of 
17 mS. Figure 11 shows a 7.5% SDS polyacrylamide gel of 
the Fab and Fe fragments isolated in this way stained with 
coomassie blue. The Fab and Fe fragments of 29Bl were 
similar. The Fe fragments of both 29Bl and UPC-10 were 
retained on a Protein A-sepharose affinity column in 0.15 M 
NaCl, 0.02 M NaH2Po4 , pH 7.6 buffer. The Fab fragments of 
both these immunoglobulins showed no affinity for the Protein 
A affinity column. 
Labeling of Fab and Fe Fragments by HMNB-DMSBr 
The covalent incorporation of HMNB-DMSBr labels per IgG 
molecule was found to be 0.4 and the molar ratio of label to 
61 
Fab fragment was 0.12. This analysis was performed spectra-
photometrically using£= 17,500 at 410 nm for the HMNB 
. . 0 1 l% mo1ety 1n . M NaOH and E1 = 14 at 280 nm for both whole em 
IgG and Fab in 0.15 M NaCl, 0.02 M NaH 2Po4 pH 7.4 (Eisen, 
Simms, and Potter, 1968). The ratio of HMNB moieties to 
Fe was calculated to be 0.16 using the formula X = 2 X b + w a 
Xc where Xw is the ratio of label incorporation in whole 
IgG, X b is the same ratio for Fab and X is that ratio for a c 
Fe. These values were for native IgG. Reduced and alkylated 
IgG was found to be 1.14 times more reactive than native IgG 
but with approximately the same distribution between Fab 
and Fe. 
Table I summarizes the results of labeling done in the 
presence and absence of antigen under these conditions. 
The counts incorporated in either DNP 1-cytochrome C or the 
HNB-cytochrome C were less than 0.4% of the counts incorporated 
in the inununoglobulin in the same reation. The monovalent 
antigen concentration was sufficient to occupy greater than 
90% of the antigen binding sites. There was no detectable 
reaction of HMNB-DMSBr with the levan antigen. 
Complement Assays of Native or Reduced and Alkylated 
Immunoglobulins 
Figures 12 and 13 compare the difference in complement 
fixing ability of native 29Bl IgG with DNP 30 -BSA and UPC-10 
IgG with levan to that of the reduced and alkylated immuno-
globulin. The assay was performed using either 20 ~g of 
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29Bl IgG or 5 ~g of UPC-10 IgG per well and varying amounts 
of antigen. Reduced and alkylated 29Bl IgG showed 
essentially no fixation over the range of antigen concen-
tration in which native 29Bl IgG fixation began at 20% and 
progressed to 100%. Native UPC-10 IgG fixed from 40% to 80% 
of the available complement as the amount of levan per well 
was increased from 0.3 ng to 1.2 ng. At the same antigen 
concentrations the reduced and alkylated UPC-10 IgG fixed 
at most 20% of the complement. 
Figure 14 shows a gel scan at 590 nm of a 7.5% SDS 
polyacrylamide electrophoresis gel of reduced and alkylated 
UPC-10 IgG which had been stained with coomassie blue in 
10% acetic acid, 25% isopropyl alcohol, and 65% water 
(v:v:v) solution. Little intact IgG remains and most of the 
disulfide bonds between the heavy chains have been reduced. 
Similarly treated 29Bl showed corresponding peaks but in this 
case no intact IgG w~s observed. Bacterial levan (75 ~g) 
precipitated 72% as much of the reduced and alkylated IgG 
as was precipitated by the same amount of antigen acting on 
native IgG. The reduced and alkylated 29Bl IgG could not 
be eluted from a DNP-sepharose affinity column by washing 
with 5 void volumes of 0.15 M NaCl, 0.02 M NaH 2Po4 , pH 7.4 
buffer. As with the native form, the reduced and alkylated 




The changes in tryptophan reactivity resulting from 
antigen binding are summarized in Figure 15. For the 
native immunoglobulins, hapten only slightly increases 
reactivity while monovalent and multivalent antigens 
significantly decrease the reactivity of tryptophan residues 
in the Fe region. We interpret this decrease as reflecting 
a change in conformation or motional freedom of regions of the 
Fe tail of IgG which has bound antigen such that tryptophan 
residues are, on the average, less available to reagent in 
solution. The monovalent antigen is probably too small to 
interfere sterically with the Fe tryptophan residues 
and the monovalency of the antigen keeps the 29Bl IgG in 
monomeric form throughout the reaction. Since UPC-10 IgG 
was slowly added to an excess of antigen, no precipitable 
complexes formed. Those complexes which may have been 
created by this process remained soluble and were probably 
small so that intermolecular Fe interaction as a steric 
hindrance to reactivity is not a likely cause of the decrease 
observed in the reactivity of tryptophan in the UPC-10 Fe 
region. Levan, being a large polymer, could conceivably 
hinder reactions occurring in the Fe region; this 
possibility will be discussed later. 
The observed dependence of Fe tryptophan reactivity 
on the presence of antigen correlates well with the complement 
fixation study performed by Brown and Koshland (1975) on IgM. 
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They found that while IgM would fix complement when either a 
monovalent or multivalent antigen was bound, binding hapten 
was insufficient to cause fixation. This suggests a 
functional dichotomy between hapten and either monovalent 
or multivalent antigen which in the present work is 
manifested as changes in chemical reactivity of tryptophan 
residues in the Fe region of immunoglobulins. 
Reduction and alkylation of the immunoglobulin either 
negated or completely reversed the decrease in Fe tryptophan 
reactivity. Thus, the tryptophan residues in the Fe region 
of reduced 29Bl IgG showed a slight increase in reactivity 
in the presence of antigen while reduced UPC-10 IgG Fe 
displayed a marked increase in tryptophan reactivity in the 
presence of levan. The effects of reduction and alkylation 
on the observed changes in reactivity correlate with the 
loss of complement activity after reduction and alkylation 
of the antibody (Johnson and Hoffmann, 1981). A study of 
conformational changes of reduced and alkylated IgG 
(Seegan et aZ., 1979) found that when small complexes of 
reduced and alkylated IgG from rabbits were formed by binding 
a divalent antigen, the CH 2 domain adopted a very open 
structure (Figure 16). This alteration in structure was not 
observed for monomeric, reduced and alkylated IgG. 
Accordingly, the large increase in Fe tryptophan reactivity 
for reduced and alkylated UPC-10 IgG can be related to this 
conformational change which provides for greater solvent 
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exposure of the CH 2 domain because the multivalent antigen 
may be capable of mimicking the formation of soluble 
complexes as seen for rabbit IgG. If the observed decrease 
in reactivity of native UPC-10 IgG Fe were due to steric 
hindrance of the Fe region by levan then one would have 
expected the same hindrance in the reduced and alkylated 
immunoglobulin because the distance from the binding site 
to the CH 2 domain is only slightly increased by reduction 
(Seegan et aZ., 1979). As no decrease in reactivity of 
Fe tryptophan residues was observed in the reduced and 
alkylated immunoglobulin, steric hindrance seems unlikely 
to be the cause of the reactivity changes in native UPC-10 
IgG. Presumably a similar increase in Fe tryptophan 
reactivity was not observed for the reduced 29Bl system 
because only the monomeric form of the IgG was present in 
solution so that a conformational change analogous to that 
in · the UPC-10 IgG/levan complexes does not occur. 
The reactivity of Fab tryptophan residues in 29Bl IgG 
did not appear to be dependent on the presence of either 
hapten or monovalent antigen. UPC-10 IgG Fab showed 
decreases in reactivity for both the native and reduced 
and alkylated form when antigen is bound. The agreement 
in the magnitude of the decrease between the native and 
reduced and alkylated immunoglobulins supports the results 
from the quantitative precipitation of UPC-10 IgG with 
levan and indicates that the binding of antigen by the 
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protein was relatively unaffected by reduction and alkylation. 
At least three possibilities explain the observed decrease: 
(1) a tryptophan residue(s) in the antigen binding site 
is blocked when levan is bound, (2) a conformational change 
occurs in the Fab region upon binding which decreases 
tryptophan reactivity, or (3) the levan sterically blocks 
tryptophan residues which are not in the binding site. 
Presently available data do not allow one to choose among 
these alternative explanations. 
The reactivity of Fe tryptophan residues toward HMNB-
DMSBr was found to depend on the type of ligand bound and 
the integrity of the disulfide bonds in the immunoglobulin. 
This correlates with the dependence of complement activation 
on both these factors. Since the opening of the structure 
of the CH 2 region between heavy chains observed by electron 
microscopy in complexes of reduced IgG was reflected in 
increased Fe tryptophan reactivity, we believe the decrease 
in native Fe tryptophan reactivity on binding monovalent or 
multivalent antigen reflects concomitant conformational 
changes in the Fe region which allow less solvent exposure 
of tryptophan residues in this region. The conformational 
changes may be dynamic in nature and may be thought of as a 
stabilization of a less exposed conformation (Zavodszdy 
et al., 1981). 
A hypothesis detailing the relationship between 
conformational changes and complement activation has 
been formulated by Hoffmann (1976a,b,c). In the terminology 
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of allosteric conformational equilibria between a T state 
and an R state (the R state is the one that fixes complement) , 
the binding of antigen shifts the equilibrium toward the R 
form. The present results support the occurrence of a 
conformational change in the Fe region and, in terms of 
Hoffmann's R state-T state model for immunoglobulins, 
suggest Fe tryptophan residues in the R state have become 
less accessible and therefore less reactive than they are 
in the T state. 
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Table I. 3H: 14c ratios obtained for various labeled antibody-ligand systemsa 
1. Antibody-hapten 
29Bl IgG + DNP-glycine 
29Bl IgG + glycine 
2. Antibody-monovalent antigen 
29Bl IgG + DNP1-cytochrome C 
29Bl IgG + HNB-cytochrome C 
3. Reduced antibody-monovalent antigen 
R29Bl IgG + DNP1-cytochrome C 
R29Bl IgG + HNB-cytochrome C 
4. Antibody-multivalent antigen 
UPC-10 IgG + levan 
UPC-10 IgG 
b 
5. Reduced antibody-multivalent antigen 
RUPC-10 + levan 
RUPC-10 
Fab --
0.98 + 0.06 
-
0.95 + 0.05 
2.46 + 0.05 
-
2.40 + 0.05 
-
1.96 + 0.01 
-
1.92 + 0.02 
2.45 + 0.05 
2.79 + 0.05 
2.03 + 0.03 
2.31 + 0.05 
Fe 
0.99 + 0.02 -
0.95 + 0.04 -
2.10 + 0.01 
-
2.47 + 0.05 -
1.98 + 0.05 
-
1.95 + 0.02 
2.14 + 0.03 
2.77 + 0.02 
2.80 + 0.06 
2.23 + 0.05 
aEach value is the average of duplicate experiments. The error indicated is 
half the difference between the duplicate values. bAntibody which has been 




Figure 8. Elution Profile of 3H-DNP1 -cytochrorne C 
for the Hurnrnel-Dreyer Measurement of Binding Constants 
DNP1-cytochrorne C at 1.56 x 10-
5 M in 0.15 M 
NaCl, 0.02 M NaH2Po4 , pH 6.8 was used to elute 0.5 rnl 
of 29Bl IgG which was at a concentration of 6.7 x 
10-5 M in the same buffer. The counts per minute are 
for 1 rnl aliquots from each fraction collected. 






















Figure 9. Chromatograph of the Papain Digest of 
Native UPC-10 IgG 
The papain digest of UPC-10 IgG was chromatographed 
on Whatman DE-52 in a 0.05 M NaH2Po4 , pH 6.6 at room 
temperature. The Fab fragment was not retained on 
the column; the Fe fragment was eluted with a 
linear ionic gradient. The left axis of ordinates is 
the absorbance at 280 nm, the right axis of ordinates 
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Figure 10. Chromatograph of the Papain Digest of 
Reduced and A1ky1ated UPC-10 IgG 
The papain digest of reduced and a1ky1ated UPC-10 
IgG was chromatographed on Whatman DE-52 in 0.05 M 
NaH2Po4 , pH 6.6 at room temperature. The Fab fragment 
was not retained on the column; the Fe fragment was 
eluted with a linear ionic gradient. The left axis of 
ordinates is the absorbance at 280 nm, the right axis of 
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Figure 11. SDS Polyacrlyamide Gels of Fab and Fe 
Fragments 
The percentage acrylamide of the gel was 7.5%. 
Track 1 is Fab from native UPC-10 IgG; track 2 is Fe 
from native UPC-10 IgG. Tracks 3 and 4 are 
respectively Fab and Fe from reduced and alkylated 
UPC-10 IgG. Track 5 shows bovine serum albumin, 
alcohol dehydrogenase and cytochrome c. The gel was 
run under reducing conditions. 
7 8 
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Figure 12. Complement Fixation Assay Comparing Native 
29Bl IgG to Reduced and Alkylated 29Bl IgG 
Varying amounts of DNP 30 -BSA were incubated with 
20 ~g per microtitre well of native 29Bl IgG (V) or 
with 20 ~g per microtitre well of reduced and 
alkylated 29Bl IgG (0). The ordinate is the percent 
fixation of two CH50 units of guinea pig serum and 






































Figure 13. Complement Fixation Assay Comparing Native 
UPC-10 IgG to Reduced and Alkylated UPC-10 IgG 
Varying amounts of bacterial levan were incubated 
with 5 ~g of native UPC-10 IgG (V) or 5 ~g of reduced 
and alkylated UPC-10 IgG (0). The ordinate is the 
percent fixation of two cH50 units of guinea pig serum 






























Figure 14. Gel Scan of SDS-polyacrylarnide Gel of 
Reduced and Alkylated UPC-10 IgG 
The scan of reduced and alkylated UPC-10 IgG 
on 7.5% polyacrylamide was made at 590 nm observing 
the coomassie blue used to visualize the products 
of reduction. Peak A is light chain and peak B is 
heavy chain. The molecular weights for the rest of 
the peaks were determined to be C = 81 kilodaltons, 
D = 108 kilodaltons, E = 126 kilodaltons, and F = 
150 kilodaltons by the plot of ln[molecular weight] 
versus Rf using A and B as standards. 
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Figure 15. Summary of Changes in Tryptophan 
Reactivities for Various Antibody/Ligand Systems 
The upper 5 bars are for Fab fragments and the 
lower 5 bars are Fe fragments. The changes are 
expressed in percentage change of incorporation of 
label in the presence of ligand compared to incorporation 
of label in the absence of ligand. 
Fab fragments 
29Bl IgG + DNP-glycine 
29Bl IgG + DNP1-cytochrorne C 
R29Bl IgG + DNP1-cytochrorne C 
UPC-10 IgG + levan 
RUPC-10 IgG + levan 
Fe fragments 
29Bl IgG + DNP-glycine 
29Bl IgG + DNP1-cytochrorne C 
R29Bl IgG + DNP 1-cytochrorne C 
UPC-10 IgG + levan 
RUPC-10 IgG + levan 




Figure 16. Schematic of Structural Change Observed 
for Reduced and Alkylated Rabbit IgG (Seegan et al., 
1979) 
The binding of multivalent antigen gives rise to 
an open structure in the CH2 domain. RS represents 




Complement Fixation by Dimers and Trimers of 
29Bl IgG Produced by Chemical Crosslinking 
One central piece of evidence for the aggregation 
theory of complement activation is the ability of aggregates 
of IgG produced by heat denaturation (Ishizaka and Ishizaka, 
1960) or chemical crosslinking (Ishizaka et aZ., 1962; 
Wright et aZ., 1980a) to activate complement. Any 
conformational requirements on the IgG molecule in the 
aggregate appear to be restricted only to the size of the 
aggregate because the ability to activate complement seems 
independent of the method used to generate the aggregate 
and therefore independent of any specific conformational 
change in the IgG molecule (Metzger, 1974). 
The aggregation model can account for the cooperativity 
of Cl binding to antigen-antibody complexes observed by 
Thompson and Hoffmann (1974), if one allows for multiple 
Cl sites on IgG which are masked while free in solution but 
are revealed by aggregation (Metzger, 1974; Hoffmann, 1976). 
This does not account for complement activation studies 
using rabbit IgG and monovalent antigen (Goers et aZ., 
1977) . This study found that monovalent antigen increased 
the binding of Cl with IgG; this result indicated the 
occurrence of some structural alteration to produce this 
increased affinity. However it is important to note that 
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the increased affinity was not observed for Clq binding and 
that the monovalent antigen used, 2,4-dinitrophenyl poly-L-
lysine20, interacted with the Cl components Clr and Cls in 
a manner that was not completely defined. 
Furthermore, the ability of IgG aggregates produced by 
heat denaturation to activate complement components subse-
quent to Cl has been examined. By monitoring histamine 
release from granulocytes as an assay for C3a production, 
Hartman and Glovsky (1981) found that aggregates produced by 
heat denaturation were much less efficient at producing C3a 
than antigen-antibody aggregates containing the same amount 
of immunoglobulin. Likewise Dodds and Porter (1979) found 
that 100 times more immunoglobulin in aggregates produced by 
heat denaturation is required to activate C4 via the 
classical pathway compared to immunoglobulin in antigen-
antibody aggregates. Although chemically crosslinked Fe 
fragments appear to activate complement (Ishizaka et aZ., 
1962); evidence has accumulated which indicates that IgG 
interaction with C4 and possibly C3 in addition to Cl may be 
required for cytolytic capability (Campbell et aZ., 1980). 
This result may indicate that a reasonably precise relation-
ship between the Fe region, c1 , and the Fab region must 
exist for C4 to be activated in such a manner as to proceed 
with subsequent proteolysis. 
One method of aggregation by chemical crosslinking has 
been developed in which dithiobissuccinimidyl propionate 
is used to crosslink rabbit IgG and produce oligomers of the 
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immunoglobulin which can then be separated into dimers, 
trimers, and tetramers by gel filtration chromatography 
(Wright et aZ., 1980b). This study demonstrated an 
affinity between these oligomers and Clq by analytical 
ultracentrifugation. This same work used the assay system 
of Levine and van Vunaki (1967) to assay for complement 
fixing ability of these oligomers of IgG. By this assay 
system, oligomers of crosslinked rabbit IgG fixed complement 
with tetramer requiring 100 times less protein than trimer 
to achieve 50% fixation and trimer requiring 10 times less 
protein than dimer for this level of fixation. Monomeric 
IgG did not fix complement by this assay. 
The assay of Levine and van Vunakis may be categorized 
as a complement depletion assay which, with various modifi-
cations, has been used for determining the activity of 
aggregated IgG and aggregated Fe from IgG (Ishizaka and 
Ishizaka, 1960; Ishizaka et aZ., 1962). In this type of 
assay the material in question is incubated with a source of 
complement, typically guinea pig serum, for a fixed amount 
of time under specific environmental conditions. Then a 
fixed amount of sheep erythrocytes which have been 
sensitized by exposure to anti-sheep red blood cell anti-
serum is added to the incubated guinea pig serum suspension 
and this is again incubated under specific conditions. 
By comparing the amount of sheep red blood cells incubated 
in control guinea pig serum which contains none of the test 
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material, one can obtain a measure of the amount of complement 
inactivated by the test material. Lysis of the sheep red 
blood cell will directly relate to the assembly of the 
c 5b 6789 complex on the surface of the cell. The ambiguity 
in the assay is that the diminution of any complement 
component in the serum either by degradation or complexation 
will result in the attenuation of c5b 6789 complex formation. 
As an example, if the substance under study were to degrade 
C6 without affecting any other complement components, then 
a decrease in cell lysis might be observed,though this 
observation would not directly relate to biological comple-
ment activation. 
This chapter will describe an assay system which 
distinguishes effects on the complement cascade preceding 
and succeeding the activation of C3. This new double assay 
system will be used to more narrowly localize the activity 
observed for oligomers of IgG produced by chemical crosslinking. 
MATERIALS AND METHODS 
Classical Pathway Assay 
The assay of complement fixation by the classical 
pathway was adapted from the method of Bengali et al. (1980) • 
Antigen-antibody complexes or oligomers of crosslinked 
immunoglobulin were diluted into a buffer of 0.01 M Hepes, 
0.15 M NaCl, 0.00015 M CaC1 2 ·2H20, 0.0005 M MgC1 2 •6H20, 
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pH 7.4 with 0.1% gelatin (w:v) [Hereafter referred to as 
classical buffer]. Guinea pig serum was diluted 30-fold 
with classical buffer and 10 ~1 of this complement source 
were incubated in wells of a microtitre plate with 65 ~1 
of the immunoglobulin solution for 45 minutes at 37°C 
in a Lab-line Incubator which maintained a constant 
temperature, humidity, and atmospheric co2 content. 
Then SO ~1 of a 2% suspension of sensitized sheep red 
blood cells (cells and hemolysin from Flow Labs Inc.) 
which had been loaded with Slcr-Na2cro4 were added to 
each well and this suspension was incubated for an 
additional 4S minutes at 37°C. After centrifuging the 
microtiter plate at 1000 x g for 3 minutes at 4°C, 40 ~1 
aliquots of supernatant were removed and counted on a 
Beckman 4000 Gamma counter. The zero percent fixation 
level was determined by the incubation of guinea pig serum 
in classical buffer for 4S minutes at 37°C prior to the 
addition and incubation of SO ~1 of the 2% sensitized sheep 
red blood cell suspension. This control showed that the 
concentration of guinea pig serum was sufficient to lyse 
92% of the total number of cells added. The background for 
100% fixation was established by incubating SO ~1 of the 
2% erthrocyte suspension in 7S ~1 of classical buffer and 
counting 40 ~1 of this supernatant. Other controls were 
preincubation of monomeric IgG in the absence of antigen with 
guinea pig serum and preincubation of antigen with guinea 
pig serum prior to the addition of sensitized erythrocytes. 
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Each antibody-antigen concentration, oligomer concentration, 
and control were assayed in quadruplicate. 
Combined Classical-Alternate Pathway Assay 
This assay was based on the classical pathway assay 
of Bengali et al. (1980) and the alternate pathway assay of 
Riches and Stanworth (1980). The source of complement was 
human serum diluted by a factor of 2.5 with classical buffer. 
Rabbit erthrocytes obtained under sterile conditions by 
cardiac puncture were repeatedly washed and suspended in a 
buffer of 0.01 M Hepes, 0.15 M NaCl, 0.007 M MgC1 2 •6H20, 
0.02 M EGTA pH 7.2 with 0.1% gelatin [hereafter referred to 
51 as alternate buffer] and loaded with Cr-Na2cro4 in the same 
manner as was used for sheep erythrocytes. Antigen-antibody 
complexes, oligomers of crosslinked immunoglobulin G, 
monomeric antibody, and antigen were diluted to various 
concentrations with classical buffer. Then to each well of 
a microtitre plate was added 50 ~1 of the immunoglobulin 
solution followed by 50 ~1 of the diluted human serum. 
The resulting activation solution was incubated for 75 
minutes at 37°C continually maintaining constant temperature, 
humidity, and atmospheric co2 content. Then 25 ~1 of a 2% 
suspension of rabbit red blood cells were added and a second 
incubation at 37°C was performed for 45 minutes. Sensitized 
sheep erythrocytes (25 ~1 of an 8% suspension in classical 
buffer) were added to wells which corresponded to each 
experimental condition assayed for by the rabbit erythrocytes 
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and these suspensions were also incubated for 45 minutes. 
Following the second incubation period the microtitre plates 
were centrifuged at 1000 x g for 3 minutes at 4°C and 40 ~1 
aliquots of the supernatant removed and counted as 
previously described. Control conditions like those 
included for the classical pathway assay were included in 
this assay and the zero percent fixation control showed 90% 
lysis of rabbit erythrocytes under these conditions and 
73% lysis of the sensitized sheep erythrocytes. 
Time Course of Classical Pathway Complement Fixation 
Guinea pig serum was diluted as described in the 
Classical Pathway assay. The diluted guinea pig serum 
(0.27 ml) was incubated with 1.73 ml of 29Bl dimer (1.1 mg/ml) 
or 29Bl IgG trimer (0.06 mg/ml) at 37°C. Then at various 
times 75 ~1 aliquots of this solution were added to 50 ~1 
of a 2% suspension of sheep erythrocytes in classical 
buffer which had been loaded and sensitized as described 
for the Classical Pathway assay. The erythrocyte suspension 
was incubated at 37°C for 45 minutes, centrifuged at 1000 x g 
for 3 minutes at 4°C and 40 ~1 of supernatant were removed 
and counted. 
Crosslinking IgG 
Immunoglobulin G from the hybridoma 29Bl (Oi and 
Herzenberg, 1979) was produced and isolated by the method 
described in Chapter 3 of this thesis. The procedure used 
to crosslink 29Bl IgG was a modification of "Method B" by 
96 
Wright et aZ. (1980b). Immediately after the crosslinking 
reaction had proceeded for two hours, the protein-reagent 
solution was chromatographed on Sephadex G-25 (5.0 x 20 em) 
eluted with 0.15 M NaCl, 0.02 M NaH2Po4 , pH 7.4 in order 
to rapidly separate the immunoglobulin from any unreacted 
reagent. Then the protein solution was applied to an LKB 
Ultragel AcA 34 column (2.5 x 120 em) and the protein was 
eluted with the same saline-phosphate buffer used for the 
previous G-25 column. After separately pooling monomeric 
and dimeric IgG fractions, the protein peak which contained 
trimeric and larger oligomers was applied to an LKB Ultragel 
AcA 22 column (2.5 x 140 em) and the same saline-phosphate 
buffer was again used as the eluent. The dimer was 
rechromatographed on the Ultragel AcA 34 column and trimer 
was rechromatographed on the Ultragel AcA 22 column. The 
purity of these oligomers was determined by SDS electrophoresis 
on a 4% acrylamide slab gel which was stained with coomassie 
blue to visualize the proteins. The dimer and trimer were 
stored at -70°C until used in the complement assay; the 
oligomers had previously been shown to be stable for as long 
as two months under these conditions (Wright et aZ., 1980a). 
Synthesis of DNP-antigens 
DNP
1
-cytochrome C and DNP 30 -BSA were prepared as described 
in Chapter 3. 
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RESULTS 
Classical Pathway Complement Assay of 29Bl IgG Dimer 
and Trimer 
A 4% acrylamide gel of 29Bl monomer, dimer, and trimer 
showed some contamination of dimer with trimer and trimer 
with tetramer. The yields of dimer, trimer, and higher 
oligomers were 20%, 8%, and less than 4%, respectively. 
The classical pathway complement assays using guinea pig 
serum are shown in Figure 17 for 29Bl IgG dimer and Figure 18 
for 29Bl IgG trimer. The 50% fixation point for the dimer 
occurred at an immunoglobulin concentration of 9.5 x 10-6 M 
while the same level of fixation was achieved for the trimer 
at 2.0 x 10-6 M. It should be made clear that the amount of 
immunoglobulin required to achieve 50% fixation varied by as 
much as 20% from preparation to preparation. When the 
oligomers were reduced with dithiothreitol by a published 
procedure (Wright et aZ., 1980b), no fixation was observed 
over the same range of immunoglobulin concentrations. 
Classical-Alternate Pathway Combined Assay of 29Bl Oligomers 
The results of the combined assay are shown in Figure 19 
for 29Bl IgG dimer and Figure 20 for 29Bl IgG trimer. As 
the concentration of either oligomer increased, the lysis 
of sensitized sheep red blood cells decreased but no change 
occurred in the level of alternate pathway lysis of rabbit 
red blood cells. When the same assay system was applied to 
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antigen-antibody complexes, a concomitant decrease in both 
sheep and rabbit erythrocyte lysis was observed. Figure 21 
shows the complement fixation of 6.7 x 10-7 M IgG with 
increasing amounts of DNP 30 -BSA and Figure 22 plots the 
same results for an IgG concentration of 6.7 x 10-6 M. 
At the antigen concentrations used in this assay, DNP 30 -BSA 
alone did not cause observable fixation. To insure that no 
lysis by the classical pathway was observed for rabbit 
erythrocytes in alternate buffer, an 8% suspension of 
sensitized sheep erythrocytes in alternate buffer was 
added to the zero fixation control wells and less than 2% 
lysis of these cells occurred. The oligomers of immuno-
globulin were assayed over the same range of DNP 30 -BSA 
concentrations that was used for monomeric 29Bl IgG. 
The alternate pathway lysis of rabbit red blood cells under 
these conditions is shown in Figures 23 and 24. Oligomers 
of 29Bl IgG are capable of diminishing lysis of rabbit red 
blood cells when further complexation of the oligomers by 
polyvalent antigen has occurred. In the presence of a 
large excess of DNP 1-cytochrome C (2 x 10-
3 M) the oligomers 
did not show any significant decrease in the amount of 
rabbit red blood cells lysed by human serum as seen in 
Figures 25 and 26. 
Time Course of Classical Pathway Complement Fixation by 
Oligomers of 29Bl IgG 
The fixation of guinea pig serum as a function of 
time by dimers of 29Bl IgG is shown in Figure 27. A 
similar result was obtained for 29Bl IgG trimer as seen 
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in Figure 27. The zero percent fixation control showed 
that guinea pig serum diluted with classical buffer does not 
spontaneously degrade at 37°C. Both oligomers produce, 
over a period of hours, continuous decreases in the ability 
of the incubated guinea pig serum to lyse sensitized sheep 
erythrocytes. 
DISCUSSION 
A greater amount of 29Bl IgG oligomer was required to 
fix guinea pig serum complement in the classical pathway 
assay of this work as compared to oligomers of rabbit IgG 
by the assay system of Levine and van Vunakis (Wright 
et al., 1980b). Several factors probably contribute to 
this difference. Among these factors are: (1) the 
possibility that the species differences between rabbit 
IgG and mouse IgG2a give rise to differing abilities to 
fix guinea pig complement, and (2) the time and temperature 
of the preincubation in the absence of erythrocytes are 
different in these two assays. 
The combined classical-alternate pathway assay 
simultaneously gauges the cytolytic ability of the Cl-C9 
system and of the C3-C9 system after preincubation of the 
test material with human complement. The results of this 
assay on oligomers of 29Bl IgG show an effect on some 
component or components of the classical pathway by these 
oligomers. Furthermore, the component affected does not 
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seem to participate in the alternate pathway which focusses 
attention on Cl, C2, and C4 as the components which might be 
affected by oligomers of 29Bl IgG. The positive control 
of this assay which uses antigen-antibody aggregates insures 
that an observed fixation of the Cl-C9 system by a 
biologically competent complex is concomitant with fixation 
of the C3-C9 system. Additionally the assay of the complexes 
comprised of antigen and chemically crosslinked IgG 
indicates that the immunoglobulin has not become impotent 
as a result of chemical modification. However, no increase 
in the inactivation of the C3-C9 system was observed for 
oligomers of 29Bl IgG in the presence of the monovalent 
antigen DNP1-cytochrome c. 
The apparent fixation of the classical pathway system 
by 29Bl IgG oligomers could arise from either binding some 
combination of components Cl, C2, and C4 thereby decreasing 
their contribution to cytolysis; or activating the first 
component in a manner resembling the system in vivo but 
failing to achieve the formation of c14b 2a; that is C3 
convertase, thereby leaving the components involved in the 
alternate pathway unchanged. The time course of classical 
pathway fixation gives more credence to the latter hypothesis. 
If complement components were merely being sequestered then 
one would expect a plateau in the time course of fixation 
once the binding equilibrium had been established. But even 
in the case of the trimer followed for four hours, the 
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remaining cytolytic capability of the solution continues 
to decrease. This continued decline probably results from 
the enzymatic proteolysis, activation, and spontaneous 
inactivation of components in the cascade preceeding the 
formation of C3 convertase. 
The evidence obtained from analytical ultracentrifugation 
that oligomers of rabbit IgG bind Clq seems reliable. 
However the binding of Clq and even the production of 
Cl should not be considered equivalent to activation 
of the cascade. The work of Allan and Isliker (1974) 
found that tryptophan derivatization may be manipulated 
in such a way as to considerably reduce complement activation 
by rabbit IgG while only slightly diminishing Clq binding 
by the modified IgG. The Dodds and Porter study (1979) 
found that aggregates produced by heat denaturation 
activated Cl which went on to proteolyze C4, but at a rate 
much less than that of antigen-antibody complexes. These 
authors speculated that the enzymatic activation of C3 
was not achieved by the formation of C3 convertase but 
instead as executed by c- in a manner analogous to the 
1 
activation of complement by proteases, such as trypsin, 
which are exogenous to the cascade (Arroyave, 1972). 
The overall implication of the complement assays 
performed on oligomers of 29Bl IgG is that chemically 
crosslinked IgG does not closely duplicate the biological 
activity of antigen-antibody aggregates; therefore 
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mechanistic arguments based on studies of such synthetic 
oligomers should be cautiously formulated. While the 
process of IgG oligomerization is important to complement 
activation, it does not seem to be sufficient for the 
activation of complement. 
One possible explanation for the functional difference 
between aggregates produced by chemical crosslinking versus 
those produced by antigenic crosslinking is that the 
antigen molds the orientation of Cl and IgG to proceed 
with activation. The covalent attachment of C4b to the 
Fd portion of IgG appears to be rather specific in that 
no attachment to the light chain has been observed 
(Campbell et aZ., 1980). If antigen serves to provide 
the proper conformation and structural rigidity of the 
IgGnCl complex, then the results of the complement assays 
of chemically crosslinked oligorners of IgG and such IgG 
oligomers in the pres~nce of monovalent antigen described 
in this work are not surprising because neither system 
appears to provide structural rigidity. 
A hypothesis of this sort requires the examination 
of the effects antigen has on the interaction of IgG 
not only with Cl but also those components succeeding 
Cl in the complement cascade. This broadened scope 
generates increased complexity in the formulation of a 
molecularly detailed mechanism for complement activation 
by the classical pathway. 
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Figure 17. Classical Pathway Complement Assay of 
(29Bl IgG) 2 
The ordinate is the % lysis of sensitized sheep 
erythrocytes by guinea pig serum which had been 
preincubated with varying amounts of (29Bl IgG) 2 . 
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Figure 18. Classical Pathway Complement Assay of 
(29Bl IgG) 3 
The ordinate is the % lysis of sensitized sheep 
erythrocytes by guinea pig serum which had been 
preincubated with varying amounts of (29Bl IgG) 3 . 
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Figure 19. Combined Classical-Alternate Pathway 
Assay for (29Bl IgG) 2 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway (0) or sheep erythrocytes by 
the classical pathway (0) . The source of complement 
was human serum which had been preincubated in classical 
buffer with varying amounts of (29Bl IgG) 2 . The abscissa 
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Figure 20. Combined Classical-Alternate Pathway Assay 
for (29Bl IgG) 3 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway (0) or sheep erythrocytes by 
the classical pathway (0). The source of complement was 
human serum which had been preincubated in classical 
buffer with varying amounts of (29Bl IgG) 3 . The 
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Figure 21. Combined Classical-Alternate Pathway Assay 
of 29Bl IgG and DNP
30
-BSA 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway (0) or sensitized sheep 
erythrocytes by the classical pathway (0). The 
source of complement was human serum which had been 
preincubated with 29Bl IgG (6.7 x 10-7 M) and 
varying amounts of DNP
30
-BSA. The abscissa is the 
amount of DNP
30
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Figure 22. Second Combined Classical-Alternate 
Pathway Assay of 29Bl IgG and DNP
30
-BSA 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway (O) or sensitized sheep 
erythrocytes by the classical pathway (0). The source 
of complement was human serum which had been 
preincubated with 29Bl IgG (6.7 x 10-6 M) and 
varying amounts of DNP 30 -BSA. The abscissa is the 
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Figure 23. Combined Classical-Alternate Pathway Assay 
of (29Bl IgG) 2 and DNP 30-BSA 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway. The source of complement was 
human serum which had been preincubated in classical 
buffer with (29Bl IgG) 2 and varying amounts of DNP 30 -BSA. 
The IgG concentration for each well was 2.7 ~M. The 
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Figure 24. Combined Classical-Alternate Pathway Assay 
of (29Bl IgG) 3 and DNP 30 -BSA 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway. The source of complement was 
human serum which had been preincubated in classical 
buffer with (29Bl IgG) 3 and varying amounts of DNP 30 -BSA. 
The IgG concentration for each well was 2.7 ~M. The 
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Figure 25. Combined Classical-Alternate Pathway Assay 
of (29Bl IgG) 2 and DNP1 -cytochrome C 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway. The source of complement was 
human serum which had been preincubated in classical 
buffer with varying amounts of either (29Bl IgG) 2 (0) 
or (29Bl IgG) 2 and DNP1-cytochrome C at a concentration 
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Figure 26. Combined Classical-Alternate Pathway Assay 
of (29Bl IgG) 3 and DNP 1-cytochrome C 
The ordinate is the % lysis of rabbit erythrocytes 
by the alternate pathway. The source of complement was 
human serum which had been preincubated in classical 
buffer with varying amounts of either (29Bl IgG) 3 (0) 
or (29Bl IgG) 3 and DNP 1-cytochrome Cat a concentration 
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Figure 27. Time Course of Complement Fixation by 
(29Bl IgG) 2 
The ordinate is the % lysis of sensitized sheep 
erythrocytes by the classical pathway. The source of 
complement was guinea pig serum which had been 
preincubated with (29Bl IgG) 2 at a concentration of 
11 ~M (0) or 29Bl IgG and DNP 30 -BSA at concentrations 
of 4.4 ~M and 0.14 ~M (0) respectively. Guinea pig serum 
which was incubated in classical buffer with no test 
material present was used to determine the 100% lysis 
level for each time point. The amount of lysis for 
these controls compared to lysis at t = 0 is shown 












~igure 28. Time Course of Complement Fixation by 
(29Bl IgG) 3 
The ordinate is the % lysis of sensitized sheep 
erythrocytes by the classical pathway. The source of 
complement was guinea pig serum which had been 
preincubated with (29Bl IgG) 3 at a concentration of 
0.32 ~M (0). Guinea pig serum which was preincubated 
in classical buffer with no test material present was 
used to determine the 100% lysis level for each time 
point. The amount of lysis for these controls compared 
to lysis at t = 0 is shown (V). The abscissa is the 










Specific Fluorescence Quenching of Tryptophan 
277 in IgG 
130 
Circularly polarized luminescence (CPL) has been used to study 
conformational changes in tmmunoglobulin G upon binding antigen 
(Schlessinger et al., 1975). One limitation of this study is that 
conclusions about the Fe region of IgG, which is the region that 
activates conplement, are inferred from differences between the CPL 
spectra of the whole immunoglobulin and the Fab fragment (Metzger, 
1974). To overcome this objection, a method for observing Fe region 
fluorescence without the modfication of the protein's tertiary 
structure by enzymatic cleavage must be found. 
The basis for such a method lies in the ability to selectively 
quench tryptophan residues in the Fe region of immunoglobulin G. 
Amino acid sequences of human and rabbit IgG (Edelman et al., 1969; 
Fruchter et al., 1970) show a tyrosine residue juxtaposed to tryptophan 
277 (Eu numbering). This particular tryptophan has been implicated 
by several researchers (Johnson and Thames, 1976; Lee and Painter, 
1980) as being the site of Clq binding or as being relevant to 
complement activation (Allan and Isliker, 1974). This is the only 
trp-tyr sequence which has been observed in the Fe region. Iodination 
of this tyrosine may quench the fluorescent emission of the tryptophan. 
When tryptophanyl tyrosine dipeptides are iodinated by the method of 
Azari and Feeney (1961), the tryptophan fluorescence is quenched to 
a large extent (figure 1). Presumably this quenching arises from the 
large p orbitals of iodine providing a facile mechanism for inter-
system crossing and the subsequent radiationless transition from 
the triplet state to the ground state (Schulman, 1977). If such 
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quenching is observed in the protein then difference spectra between 
native IgG and iodinated IgG should provide a means for observing 
those tryptophan residues that are quenched. Thus the only chemical 
modification necessary for this observation is the iodination of 
tyrosine 278 in IgG. 
The possible shortcomings of this technique stem from two 
experimental considerations. First if only two tryptophans are 
quenched per IgG, then the difference between native and iodinated 
IgG will be small; thereby requiring high sensitivity to be observed. 
This problem can be overcome by current signal averaging techniques 
(Longworth et al., 1976). Secondly sequence variability in IgG 
may lead to additional tryptophans which are juxtaposed to tyrosines. 
Definitive results would require that the difference spectra be 
consistent in the dependence on antigen binding for several IgG-
antigen systems. 
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Proposition I, figure 1. 
Emission specra of Tryptophany1 tyrosine and Tryptophany1 diiodotyrosine 
Tryptophany1 tyrosine (A) at a concentration of 1.55 x 10-~ 
-4 and tryptophanyl diiodotyrosine (B) at a concentration of 1.15 x 10 M 
in O.lOM borate buffer, pH 9.5 were irradiated at 295 nm. Spectrum 




A Heterobifunctional Photoactivated Reagent with 
Specificity for Tryptophan 
136 
Several photoreactive heterobifunctional reagents are currently 
used for crosslinking proteins (Ji, 1979). These reagents have 
diazo or azide functionalities which, upon irradiation, can produce 
reactive carbenes or nitrenes. Typically the other functionality 
in the reagent is targetted for amino, carboxyl or sulfhydryl residues 
(Das and Fox, 1979). Koshland's reagent (Horton and Koshla~, 1965) 
may provide the basis for a heterobifunctional photoactivated reagent 
which has a specificity for tryptophan. An azide group can be placed 
meta to the benzyl bromide group in the synthetic route outlined in 
figure 1. Several characteristics considered to be essential for the 
specificity of Koshland's reagent are retained in the photoactivated 
crosslinker. Among these characteristics are a hydroxyl group ortho 
to the benzyl bromide and a degree of hydrophobicity (Loudon and 
Koshland, 1970). 
One protein which provides possible applications for 3-azido-
2-hyroxy-5-nitrobenzyl bromide is immunoglobulin G. Allan and Isliker 
(1974) have shown that careful modification of two tryptophan residues 
in the CH2 domain of IgG witn Koshland's reagent only slightly decrease 
Clq binding while considerably decreasing complement activation. 
Evidence supporting the assignment of tryptophan 277 to the Clq 
binding site is reasonably strong (Johnson and Thames, 1976; Lee 
and Painter, 1980). If an immunoglobulin G modified with 3-azido-
2-hydroxy-5-nitrobenzyl bromide in the dark is used in an aggregated 
form to bind Clq, then the photoactivation of this complex might 
link the IgG to the Clq. The resulting linkage would in itself be 
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Further evidence that tryptophan 277 is in the Clq binding site. 
Also subsequent enzymatic and acidic hydrolyses could elucidate 
which amino acid residues of Clq are involved in the interaction 
with IgG. 
Presumably 3-azido-2-hydroxy-5-nitrobenzyl bromide would be 
sufficiently hydrophobic to be lipid soluble. This would allow 
the reagent to be used to chemically crosslink protein complexes 
in a cell membrane. However the retention of specificity for 
tryptophan by Koshland's reagent in a membrane would have to be 
demonstrated. 
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Proposition II, figure 1. 
Synthetic Route to 3-azido-2-hydroxy-5-nitrobenzyl bromide 
140 
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NHz (CH 20)n 
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Concentration Dependence of Products 
from Laser and Conventional Photolysis 
142 
It has recently been reported that the products from photolysis 
of diphenyldiazomethane with a laser are considerably different from 
those produced by photolysis with a conventional lamp (Turro et al., 
1980). Although the production of fluorene from the diphenylcarbene 
is an internal conversion, the major product from the photolysis of 
diphenyldiazomethane with a conventional lamo is benzophenone azine 
(Reimlinger, 1964). The major products from laser photolysis are 
fluorene, 9,10-diphenylanthracene, and 9,10-diphenylphenanthracene 
(Turro et al., 1980). Previous work by flash photolysis gave tetra-
phenylethylene as the major product from diphenyldiazomethane and this 
result was the basis for the postulation of an equilibrium between the 
singlet and triplet states of diphenylcarbene (Closs and Rabinow, 1976). 
However it is possible that the difference in the products from 
laser versus conventional photolysis is not related to the equilibrium 
between the singlet and triplet states, but is due to the concentration 
of intermediates during the course of the reaction. As diagrammed 
in figure 1, diphenyl carbene can react with diphenyldiazomethane to give 
the conventional azine (Zimmerman and Paskovich, 1964). If the intensity 
of the laser is sufficient to convert essentially all the diazo pre-
cursor into the carbene intermediate, then the major products would 
necessarily be derived from the interaction of carbenes and not the 
reaction of the carbene with the diphenyldiazomethane. 
While an increase in diphenyldiazomethane concentration did not 
increase the amount of azine formed (Turro et al., 1980), the authors 
were attempting to keep the reagents in a range of concentrations 
where Beer's Law remained applicable. Presumably one could achieve 
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increased diphenyldiazomethane concentrations in the presence of 
diphenylcarbene by attenuating the laser output. Such attenuation 
could lead to the production of the benzophenone azine and thereby 
duplicate the results of conventional photolysis. If the condition 
of increased diphenyldiazomethane concentration in the presence of 
diphenylcarbene were to be achieved by increasing the diazo concen-
tration then concentrations considerably greater than those obtained 
by Turro and his coworkers (1980) seem to be required. 
144 
Closs, G.L. and Rabinow, B.E., J. Am. Chem. Soc. (1976) 98, 8190. 
Reimlinger, H., Chem. Ber. (1964) 9?, 339. 
Turro, N.J., Aikawa, M., Butcher, J.A., and Griffin, G.W., J. Am. 
Chem. Soc. (1980) 102, 5127. 
Zimmerman, H.E. and Paskovich, D.H., J. Am. Chem. Soc. (1964) 86, 2149. 
145 
Proposition III, figure 1. 















Specific Protein Modification using 
a Polymeric Support 
148 
Because of their ease of handling, specificity, and ability to 
be regenerated; polymer-supported reagents have been used in organic 
synthesis for many years (Gainelli et al., 1981). The derivatization 
of proteins might be made more selective by having the reagent on a 
support and allowing the support to define the microenvironrnental 
characteristics of charge, steric hindrance, and solvation. For 
example, the microenvironment of the support can be made more 
hydrophobic by introducing hydrocarbon chains in the monomer of 
the support (Dubin and Levy, 1981). The selectivity of a support 
might be made more specific if an affinity for a particular region 
of the protein to be derivatized can be imparted to the support. 
Such affinity might be developed from the concept of surface 
simulation (Atassi, 1978). Surface simulation is the process of 
modeling the three dimensional structure of a protein by a linear 
sequence of amino acids. Atassi and his coworkers located the 
antigenic site of chicken lysozyme and then simulated this site with 
a polypeptide consisting 'of a linear sequence of those amino acids 
which appear to be juxtaposed in the tertiary structure of the protein. 
The resulting polypeptide cross-reacted with anti-lysozyme sera; 
thereby indicating that the three dimensional antigenic site was 
simulated by the linear polypeptide. 
This technique of linear simulation could be used to give a 
polymeric support an affinity for a specifia. region of a protein. 
Given a system of protein to be derivatized (abbreviated PrD) and 
a second protein (abbreviated PrA), such as an antibody to or 
receptor for PrD; a surface analysis of PrA should lead to a poly-
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peptide sequence which would likely have an affinity for PrD. Then 
by linking this linear polypeptide to the support of the modifying 
reagent, a specific region of PrD would be brought into close prox-
imity with the reagent. A similar concept would apply to the 
derivatization of enzymes in the vicinity of binding sites by 
covalently linking substrate or cofactor analogs to the support. 
If no PrA is known or for some reason cannot be analyzed, then 
surface complementarity (Atassi, 1978) might enable one to deduce 
an appropriate sequence for the linear polypeptide. An analysis 
of the three dimensional surface of PrD 1vould lead to a linear poly-
peptide which simulates that surface. Then a complementary poly-
peptide might be made by matching positive charges of the original 
polypeptide to negative charges on the complementary polypeptide, 
negative charges on the orginal polypeptide to positive charges on 
the complementary polypeptide, hydrophobic residues to hydrophobic 
residues, and hydrogen bonding functionalities to hydrogen bonding 
functionalities. For example, Atassi found that the polypeptide 
FGKKNTD simulated the antigenic site of lysozyme. A complementary 
polypeptide might have W correspond to F, E correspond to K, and K 
or H correspond to D. Such a complementary structure might have 
an affinity specifically for the antigenic site of chicken lysozyme. 
To continue this example further, if one wished to specifically 
reduce the disulfide at the antigenic site [C(72)-C(94)] then a 
support such as styrene derivatized with 2-hydroxyphenol and the 
polypeptide WGEEAHH might provide the proper selectivity to reduce 
only this disulfide by virtue of the affinity of the complementary 
polypeptide for the antigenic site. 
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Proposition V 
The Association of Lipids with 
the Terminating Complex of Complement 
152 
Several models for the mechanism of cytolysis by c
566789 
have 
been proposed. Three of these are: (1) the leaky patch model, (2) 
the doughnut model (Mayer, 1972) and (3) the localized disorder 
model (Esser et al., 1979). The leaky patch model proposes an 
enzymatic mechanism similar to phospholipase as a mechanism 
cytolysis. The doughnut model is based largely on electron micro-
scopic evidence and concludes that lesions observed on the membrane 
are ionophoric channels which allow the transport of water and salts; 
thereby disrupting the membrane with osmotic pressure. The localized 
disorder model states that the lytically active c5b6789 complex 
has the ability to disorder the phospholipid bilayer in the vicinity 
of the complex. Esser and his coworkers (1975) observed such 
disordering in the ESR spectra of lipid spin-labels in the membrane 
and they speculated that disarrangement of the bilayer would be 
sufficient to degrade its integrity and allow lysis without invoking 
an enzymatic degradation of the phospholipid components of the 
membrane. 
The association of detergent with c5b6789 in solution has been 
demonstrated (Podack et al., 1979) and a recent photolabeling study 
(Hu et al., 1981) indicates a similar association in membranes. 
There is a decided functional difference between c5b6789 in solu-
tion and c5b6789 in the membrane and this difference is that 
c5b6789 can be removed from the membrane of a lysed cell and will 
retain its lytic activity (Bhakdi et al., 1978) while a stable 
complex of c5b6789 with lipid formed in solution has no cytolytic 






complex is formed in the membrane (Boyle and Borsos, 1980). 
It is possible that the stability of the complex may extend 
beyond its protein components to include lipids from the membrane 
being lysed. In terms of the localized disorder model those lipids 
which are disarranged by c5b6789 are in strong association with the 
protein complex. One technique which could give insight into this 
possibility is a modification of the spin-label study which serves 
as a basis for the localized disorder model (Esser et al., 1979). 
If the concentration of the spin-label analog of lecithin is 
sufficiently high then the exchange rate will be sufficient to 
coalesce the triplet of the nitroxide radical to a single, broad 
peak. Then after isolating the c5b6789 complexes and introducing 
them into new membranes, the ESR spectrum of the new membranes would 
provide information as to the quantity of lipid transferred with 
the complex from the original membrane. Furthermore since the 
1 cal concentration of spin-label would be high about the newly 
inserted complexes, the dissipation of rapid spin-exchange would 
provide a measure of the stability of the complex in the membrane by 
an analysis similar to that used for the dissipation of rapid 
spin-exchange by phospholipid diffusion (Devaux and McConnell, 1972). 
As the lipids in the original complex began to exchange with those 
in the new membrane the spin-exchange rate would decrease and 
the dinetics of the exchange of lipids could be followed. 
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